| Home | Overview of gut regions | Anatomy | Histology | Transgene expression mapping | Gene expression |
Mean expression enrichment by gut region
| Filter out everything which GO terms when the expression scale ratio is comprised between -1.5 and 1.5 for all regions |
| GO term | Number of genes | Crop / Full gut | R2 / Full gut | R3 / Full gut | R4 / Full gut | R5 / Full gut | Hindgut / Full gut | Cardia/R1 / Full gut |
|---|---|---|---|---|---|---|---|---|
| 'de novo' GDP-L-fucose biosynthetic process | 2 | -1.67 | 1.21 | 1.13 | 1.24 | 1.36 | -1.89 | -1.14 |
| 'de novo' IMP biosynthetic process | 6 | 1.13 | 1.02 | -1.2 | -1.03 | -1.2 | 1.78 | -1.03 |
| 'de novo' posttranslational protein folding | 2 | 1.05 | 1.15 | 1.39 | 1.19 | 1.32 | -1.27 | 1.18 |
| 'de novo' protein folding | 13 | 1.11 | 1.05 | 1.16 | 1.13 | 1.14 | -1.02 | -1.03 |
| 'de novo' pyrimidine base biosynthetic process | 6 | 1.66 | -1.0 | 1.02 | -1.03 | -1.03 | 1.11 | 1.08 |
| 'de novo' UMP biosynthetic process | 1 | 1.61 | 1.06 | 1.09 | 1.15 | 1.38 | -1.09 | 1.01 |
| 1,3-beta-D-glucan synthase activity | 1 | 12.72 | -1.88 | -1.16 | -3.3 | -1.54 | 3.13 | 2.87 |
| 1,4-alpha-glucan branching enzyme activity | 1 | 3.55 | -1.35 | -1.97 | 1.08 | 1.09 | 1.58 | 1.19 |
| 1-acylglycerol-3-phosphate O-acyltransferase activity | 6 | -1.56 | -1.19 | -1.0 | 1.18 | 2.24 | -2.62 | -1.99 |
| 1-alkyl-2-acetylglycerophosphocholine esterase activity | 1 | 3.85 | 1.07 | 1.8 | 1.09 | 1.57 | 2.16 | 1.8 |
| 1-aminocyclopropane-1-carboxylate biosynthetic process | 2 | 1.14 | 1.17 | -1.17 | -1.01 | 1.02 | 1.07 | -1.0 |
| 1-aminocyclopropane-1-carboxylate metabolic process | 2 | 1.14 | 1.17 | -1.17 | -1.01 | 1.02 | 1.07 | -1.0 |
| 1-aminocyclopropane-1-carboxylate synthase activity | 2 | 1.14 | 1.17 | -1.17 | -1.01 | 1.02 | 1.07 | -1.0 |
| 1-phosphatidylinositol 4-kinase activity | 2 | 1.44 | 1.21 | 1.76 | 1.02 | 1.71 | 2.28 | 1.63 |
| 1-phosphatidylinositol binding | 1 | -1.06 | 1.07 | 1.15 | -1.0 | 1.23 | 1.29 | 1.44 |
| 1-phosphatidylinositol-3-kinase activity | 3 | -1.46 | 1.15 | 1.53 | 1.18 | 1.77 | -1.09 | -1.14 |
| 1-phosphatidylinositol-3-phosphate 5-kinase activity | 1 | -1.33 | 1.29 | 1.91 | 1.33 | 2.36 | 1.28 | 1.16 |
| 1-phosphatidylinositol-4-phosphate 3-kinase activity | 3 | -1.46 | 1.15 | 1.53 | 1.18 | 1.77 | -1.09 | -1.14 |
| 1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex | 2 | -1.54 | 1.47 | 1.35 | 1.15 | 1.83 | 1.07 | 1.48 |
| 1-phosphatidylinositol-4-phosphate 5-kinase activity | 3 | -1.16 | 1.29 | 1.43 | 1.06 | 1.4 | 1.27 | 1.16 |
| 1-pyrroline-5-carboxylate dehydrogenase activity | 3 | 1.56 | -1.48 | -1.15 | -1.62 | -1.43 | 2.14 | 1.15 |
| 10-formyltetrahydrofolate catabolic process | 1 | -1.35 | 1.22 | 1.7 | 1.18 | 1.15 | -1.09 | 1.03 |
| 10-formyltetrahydrofolate metabolic process | 2 | 2.31 | -1.37 | 1.2 | -1.19 | -1.05 | 2.92 | 1.06 |
| 2 iron, 2 sulfur cluster binding | 15 | -1.23 | 1.2 | 1.11 | 1.01 | -1.04 | -1.03 | -1.02 |
| 2'-deoxyribonucleotide biosynthetic process | 3 | 1.12 | 1.06 | 1.16 | 1.24 | 1.35 | 1.15 | -1.08 |
| 2'-deoxyribonucleotide metabolic process | 5 | 1.18 | -1.03 | 1.1 | 1.33 | 1.37 | -1.01 | -1.27 |
| 2'-phosphotransferase activity | 1 | 3.82 | 1.09 | 1.67 | 1.1 | 1.4 | 2.3 | 1.73 |
| 2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity | 1 | 1.92 | 1.16 | 1.15 | 1.28 | 1.06 | 2.87 | -1.21 |
| 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity | 1 | 1.67 | 1.48 | 1.35 | 1.44 | 1.31 | 1.18 | 1.35 |
| 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity | 1 | 1.92 | 1.16 | 1.15 | 1.28 | 1.06 | 2.87 | -1.21 |
| 2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity | 5 | -4.34 | 1.01 | 1.27 | 1.24 | 1.5 | -3.41 | -1.26 |
| 2-oxoglutarate metabolic process | 2 | -1.13 | -1.34 | 1.15 | -1.41 | 1.89 | 2.28 | -2.14 |
| 2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity | 2 | -1.09 | 1.1 | 1.25 | 1.35 | 1.18 | 1.22 | -1.29 |
| 3'(2'),5'-bisphosphate nucleotidase activity | 2 | 1.61 | 1.02 | -1.31 | 1.13 | -1.08 | 1.03 | 1.2 |
| 3',5'-cyclic-AMP phosphodiesterase activity | 4 | 1.06 | 1.26 | 1.31 | 1.05 | 1.3 | 1.79 | 1.4 |
| 3',5'-cyclic-GMP phosphodiesterase activity | 5 | 1.32 | 1.17 | 1.39 | 1.05 | 1.28 | 2.17 | 1.4 |
| 3',5'-cyclic-nucleotide phosphodiesterase activity | 8 | 1.68 | 1.07 | 1.28 | 1.01 | 1.26 | 2.25 | 1.48 |
| 3'-5' DNA helicase activity | 12 | -1.05 | 1.14 | 1.22 | 1.27 | 1.49 | -1.11 | -1.06 |
| 3'-5' exonuclease activity | 25 | 1.2 | 1.14 | 1.2 | 1.19 | 1.29 | 1.17 | 1.03 |
| 3'-5'-exodeoxyribonuclease activity | 5 | -1.07 | 1.09 | 1.04 | -1.0 | 1.17 | 1.05 | -1.01 |
| 3'-5'-exoribonuclease activity | 15 | 1.46 | 1.13 | 1.16 | 1.27 | 1.25 | 1.2 | 1.04 |
| 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity | 2 | 1.45 | 1.3 | 1.01 | 1.18 | 1.09 | 1.6 | 1.46 |
| 3'-phosphoadenosine 5'-phosphosulfate transport | 1 | 1.9 | 1.27 | 1.23 | 1.06 | 1.26 | 2.28 | 1.58 |
| 3'-tyrosyl-DNA phosphodiesterase activity | 1 | -1.61 | -1.07 | -1.0 | -1.17 | -1.28 | -1.58 | -1.34 |
| 3-beta-hydroxy-delta5-steroid dehydrogenase activity | 1 | 7.52 | -1.63 | -1.52 | -1.44 | -1.48 | 2.76 | 1.78 |
| 3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
| 3-hydroxyacyl-CoA dehydrogenase activity | 4 | 1.05 | 1.0 | -1.41 | 1.24 | -1.28 | 1.08 | 1.21 |
| 3-hydroxyisobutyrate dehydrogenase activity | 2 | -1.14 | 1.35 | 1.05 | 1.01 | 1.01 | 1.03 | 1.42 |
| 3-hydroxyisobutyryl-CoA hydrolase activity | 1 | 1.35 | 1.24 | 1.18 | -1.16 | -1.11 | 6.95 | -1.22 |
| 3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
| 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity | 2 | 1.67 | 1.29 | 1.69 | -1.02 | 1.34 | 1.99 | 1.11 |
| 3-methyl-2-oxobutanoate dehydrogenase (lipoamide) complex | 2 | 1.67 | 1.29 | 1.69 | -1.02 | 1.34 | 1.99 | 1.11 |
| 3-oxo-5-alpha-steroid 4-dehydrogenase activity | 1 | -1.31 | 1.28 | -1.32 | 1.3 | 1.08 | -2.32 | -1.18 |
| 3-oxoacid CoA-transferase activity | 1 | -1.42 | 1.61 | -1.39 | -1.13 | -1.97 | 3.73 | -1.22 |
| 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
| 3-oxoacyl-[acyl-carrier-protein] synthase activity | 3 | 2.25 | -1.02 | -1.08 | -1.11 | 1.15 | 1.9 | 1.44 |
| 3R-hydroxyacyl-CoA dehydratase activity | 1 | -1.23 | 1.06 | -2.67 | 1.58 | 1.11 | -5.4 | -1.98 |
| 4 iron, 4 sulfur cluster binding | 15 | 1.46 | 1.1 | 1.27 | -1.03 | 1.06 | 1.96 | 1.05 |
| 4-alpha-glucanotransferase activity | 1 | 1.91 | -1.57 | -1.98 | 1.36 | -1.16 | 2.47 | 1.07 |
| 4-alpha-hydroxytetrahydrobiopterin dehydratase activity | 1 | 7.73 | -1.1 | 1.09 | -1.29 | -1.0 | 2.46 | 1.16 |
| 4-aminobutyrate transaminase activity | 1 | -1.88 | 3.07 | -1.92 | -1.52 | -1.3 | -2.05 | 1.06 |
| 4-coumarate-CoA ligase activity | 5 | -15.09 | -1.26 | -3.1 | -1.62 | -4.07 | -3.87 | -5.45 |
| 4-hydroxybenzoate octaprenyltransferase activity | 1 | 1.04 | 1.26 | 1.1 | 1.28 | -1.02 | -1.97 | -1.12 |
| 4-hydroxybutyrate CoA-transferase activity | 1 | 1.07 | 1.18 | 1.06 | 1.23 | 1.16 | -1.07 | 1.13 |
| 4-hydroxyphenylpyruvate dioxygenase activity | 1 | 1.86 | -1.07 | 1.21 | 1.03 | 1.14 | 1.09 | -1.06 |
| 4-hydroxyproline metabolic process | 15 | -1.0 | 1.02 | -1.1 | -1.04 | -1.12 | 1.01 | -1.04 |
| 4-nitrophenylphosphatase activity | 9 | -1.32 | 1.18 | -1.3 | 1.06 | 1.01 | -1.31 | 1.07 |
| 5'-3' exonuclease activity | 2 | -1.11 | 1.53 | 1.16 | 1.33 | 1.34 | -1.11 | 1.19 |
| 5'-3' exoribonuclease activity | 2 | -1.11 | 1.53 | 1.16 | 1.33 | 1.34 | -1.11 | 1.19 |
| 5'-nucleotidase activity | 7 | -2.99 | 1.07 | -1.74 | 1.18 | -1.15 | -2.4 | -1.14 |
| 5,10-methylenetetrahydrofolate-dependent methyltransferase activity | 2 | 1.05 | 1.03 | -1.1 | 1.26 | 1.31 | 1.33 | -1.09 |
| 5-(carboxyamino)imidazole ribonucleotide mutase activity | 1 | 1.05 | -1.55 | -1.44 | -1.5 | -1.3 | 3.7 | 1.09 |
| 5-aminolevulinate synthase activity | 1 | 1.58 | 1.36 | -1.31 | -1.09 | -1.26 | 1.25 | 1.23 |
| 5-formyltetrahydrofolate cyclo-ligase activity | 2 | -1.02 | 1.01 | 1.07 | 1.18 | 1.07 | 1.18 | -1.17 |
| 5-oxoprolinase (ATP-hydrolyzing) activity | 1 | -1.27 | -1.09 | -1.84 | 1.84 | -1.17 | -2.01 | -1.59 |
| 5S rRNA binding | 2 | 1.26 | 1.08 | 1.22 | 1.14 | 1.15 | 1.1 | -1.0 |
| 5S rRNA primary transcript binding | 1 | 1.17 | 1.17 | 1.25 | 1.35 | 1.14 | -1.19 | -1.07 |
| 6,7-dihydropteridine reductase activity | 1 | 2.26 | 1.17 | 1.35 | 1.12 | 1.23 | 1.64 | 1.14 |
| 6-phosphofructo-2-kinase activity | 1 | 1.09 | -1.34 | 2.59 | -1.04 | 1.14 | 3.38 | -1.06 |
| 6-phosphofructokinase activity | 1 | 2.63 | -1.22 | -1.22 | 1.02 | -1.12 | 5.11 | 1.3 |
| 6-phosphofructokinase complex | 1 | 2.63 | -1.22 | -1.22 | 1.02 | -1.12 | 5.11 | 1.3 |
| 6-phosphogluconolactonase activity | 1 | 2.54 | 1.2 | -1.43 | 1.17 | 1.05 | -1.15 | 1.18 |
| 6-pyruvoyltetrahydropterin synthase activity | 1 | 2.12 | 1.31 | 1.32 | 1.23 | 1.73 | 1.01 | 2.0 |
| 7-beta-hydroxysteroid dehydrogenase (NADP+) activity | 1 | 1.03 | -1.04 | 1.2 | -1.01 | 1.0 | 2.11 | -1.07 |
| 7-methylguanosine biosynthetic process | 2 | -1.08 | 1.07 | 1.01 | 1.12 | 1.08 | -1.67 | -1.22 |
| 7-methylguanosine metabolic process | 2 | -1.08 | 1.07 | 1.01 | 1.12 | 1.08 | -1.67 | -1.22 |
| 7S RNA binding | 6 | 1.07 | 1.41 | 1.11 | 1.17 | 1.04 | -1.21 | 1.28 |
| [acyl-carrier-protein] S-acetyltransferase activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
| [acyl-carrier-protein] S-malonyltransferase activity | 3 | 2.14 | -1.05 | -1.1 | -1.07 | 1.17 | 1.47 | 1.42 |
| [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 2 | 1.57 | 1.14 | -1.02 | 1.0 | 1.08 | -1.33 | -1.08 |
| [heparan sulfate]-glucosamine N-sulfotransferase activity | 1 | -1.1 | 1.79 | 1.14 | 1.04 | 1.02 | -1.23 | 2.55 |
| [methionine synthase] reductase activity | 1 | 1.59 | 1.02 | 1.27 | 1.16 | 1.58 | 1.37 | 1.04 |
| [pyruvate dehydrogenase (lipoamide)] phosphatase activity | 1 | 1.78 | 1.13 | 1.46 | 1.23 | 1.08 | 1.92 | 1.02 |
| [pyruvate dehydrogenase (lipoamide)] phosphatase regulator activity | 1 | 1.97 | 1.3 | 1.52 | -1.19 | 1.01 | 1.99 | 1.65 |
| A band | 9 | 1.95 | -1.09 | -1.15 | -1.11 | 1.13 | 1.79 | 1.07 |
| A-type (transient outward) potassium channel activity | 2 | 3.38 | -1.08 | 1.04 | -1.08 | 1.22 | 1.8 | -1.38 |
| absorption of UV light | 1 | -1.04 | -1.01 | -1.1 | -1.1 | -1.27 | -1.03 | -1.11 |
| absorption of visible light | 1 | -1.32 | 1.03 | -1.29 | -1.1 | -1.47 | -1.43 | -1.25 |
| acetaldehyde dehydrogenase (acetylating) activity | 2 | 2.78 | -1.16 | -2.38 | -2.31 | -1.44 | 1.4 | 1.22 |
| acetaldehyde metabolic process | 2 | 2.78 | -1.16 | -2.38 | -2.31 | -1.44 | 1.4 | 1.22 |
| acetate-CoA ligase activity | 2 | 1.63 | 1.11 | -1.36 | -1.04 | -1.71 | 1.16 | 1.18 |
| acetoacetyl-CoA reductase activity | 1 | 1.03 | -1.04 | 1.2 | -1.01 | 1.0 | 2.11 | -1.07 |
| acetyl-CoA biosynthetic process | 2 | -1.03 | 1.03 | 1.25 | -1.03 | 1.02 | 1.46 | -1.0 |
| acetyl-CoA biosynthetic process from pyruvate | 1 | 1.23 | 1.19 | 1.96 | -1.07 | 1.35 | 3.33 | 1.11 |
| acetyl-CoA C-acetyltransferase activity | 2 | 1.25 | 1.16 | -1.11 | 1.2 | -1.13 | 1.26 | -1.35 |
| acetyl-CoA C-acyltransferase activity | 4 | 1.58 | 1.11 | -1.25 | 1.12 | 1.08 | 1.06 | -1.32 |
| acetyl-CoA carboxylase activity | 1 | 7.73 | 1.2 | -1.41 | -2.71 | 1.2 | 3.14 | 4.69 |
| acetyl-CoA catabolic process | 36 | -1.0 | 1.09 | 1.26 | -1.05 | 1.07 | 1.52 | -1.04 |
| acetyl-CoA metabolic process | 39 | -1.0 | 1.09 | 1.25 | -1.05 | 1.07 | 1.5 | -1.03 |
| acetyl-CoA transporter activity | 1 | -1.28 | 1.24 | -1.24 | 1.18 | -1.13 | -1.69 | 1.59 |
| acetylcholine binding | 1 | -1.34 | -1.11 | -1.08 | -1.04 | -1.26 | -1.15 | -1.15 |
| acetylcholine biosynthetic process | 2 | 1.23 | -1.06 | -1.21 | -1.07 | 1.07 | -1.1 | -1.02 |
| acetylcholine catabolic process | 1 | 2.27 | 1.23 | -5.17 | -1.59 | -2.2 | -9.9 | 9.42 |
| acetylcholine catabolic process in synaptic cleft | 1 | 2.27 | 1.23 | -5.17 | -1.59 | -2.2 | -9.9 | 9.42 |
| acetylcholine metabolic process | 3 | 1.5 | 1.03 | -1.96 | -1.22 | -1.24 | -2.29 | 2.08 |
| acetylcholine receptor activity | 2 | 1.0 | 1.08 | 1.1 | 1.16 | 1.17 | 1.06 | 1.05 |
| acetylcholine receptor binding | 1 | -1.02 | 1.16 | 1.08 | 1.02 | 1.02 | 1.28 | 1.01 |
| acetylcholine transmembrane transporter activity | 1 | 1.16 | 1.14 | 1.1 | 1.05 | 1.08 | 1.11 | 1.02 |
| acetylcholine-activated cation-selective channel activity | 9 | -1.07 | 1.01 | -1.02 | -1.03 | -1.09 | -1.06 | -1.03 |
| acetylcholine-gated channel complex | 9 | -1.07 | 1.01 | -1.02 | -1.03 | -1.09 | -1.06 | -1.03 |
| acetylcholine:hydrogen antiporter activity | 1 | 1.16 | 1.14 | 1.1 | 1.05 | 1.08 | 1.11 | 1.02 |
| acetylcholinesterase activity | 1 | 2.27 | 1.23 | -5.17 | -1.59 | -2.2 | -9.9 | 9.42 |
| acetylgalactosaminyltransferase activity | 18 | -1.14 | -1.09 | -1.18 | -1.18 | -1.19 | -1.47 | 1.62 |
| acetylglucosaminyltransferase activity | 26 | 1.0 | 1.15 | 1.12 | 1.08 | 1.33 | 1.22 | 1.29 |
| acetyltransferase activity | 54 | -1.01 | 1.14 | 1.0 | 1.14 | 1.18 | -1.11 | 1.03 |
| ACF complex | 5 | 1.33 | -1.77 | -1.21 | -1.79 | 1.3 | 2.26 | 1.17 |
| achiasmate meiosis I | 1 | -1.17 | 1.02 | -1.13 | 1.11 | -1.02 | -1.2 | -1.13 |
| acid phosphatase activity | 12 | 1.44 | 1.13 | -1.05 | -1.03 | -1.02 | 1.81 | 1.28 |
| acid-amino acid ligase activity | 111 | 1.11 | 1.16 | 1.34 | 1.13 | 1.26 | 1.19 | 1.18 |
| acid-ammonia (or amide) ligase activity | 2 | 1.91 | -1.99 | 2.01 | -1.44 | 1.52 | -1.73 | -1.25 |
| acid-thiol ligase activity | 13 | -2.56 | -1.1 | -1.57 | -1.26 | -1.84 | -1.46 | -2.12 |
| acidic amino acid transmembrane transporter activity | 4 | -2.07 | 1.33 | -5.17 | -2.48 | -1.62 | -1.72 | -2.15 |
| acidic amino acid transport | 4 | -2.92 | -1.1 | -4.98 | -1.98 | -1.32 | -2.35 | -3.75 |
| acireductone dioxygenase [iron(II)-requiring] activity | 1 | 1.79 | 1.32 | -1.5 | 1.17 | -1.1 | 1.63 | 1.03 |
| acireductone synthase activity | 1 | 1.92 | 1.16 | 1.15 | 1.28 | 1.06 | 2.87 | -1.21 |
| aconitate hydratase activity | 4 | 1.11 | 1.25 | 1.22 | -1.14 | -1.03 | 1.75 | 1.32 |
| acroblast | 1 | -1.29 | 1.49 | 1.22 | 1.13 | 1.05 | 1.04 | 1.36 |
| acrosomal vesicle | 1 | -1.22 | 1.14 | 1.06 | 1.01 | -1.52 | -1.37 | 1.04 |
| actin binding | 114 | -1.07 | 1.06 | 1.38 | -1.0 | 1.31 | 1.09 | 1.15 |
| actin cap | 1 | 1.67 | 1.22 | 2.78 | 1.16 | 2.89 | 2.99 | 1.93 |
| actin crosslink formation | 1 | 2.2 | 1.13 | -1.01 | 1.18 | 1.16 | -1.08 | 1.17 |
| actin cytoskeleton | 94 | -1.06 | -1.02 | 1.2 | 1.01 | 1.23 | 1.08 | -1.0 |
| actin cytoskeleton organization | 160 | 1.17 | 1.02 | 1.34 | -1.03 | 1.29 | 1.3 | 1.17 |
| actin cytoskeleton reorganization | 9 | 1.38 | 1.0 | 1.56 | 1.0 | 1.39 | 1.59 | 1.34 |
| actin filament | 26 | -1.06 | -1.0 | 1.14 | -1.03 | 1.19 | 1.09 | 1.05 |
| actin filament binding | 8 | -1.01 | -1.14 | 1.31 | -1.17 | 1.11 | 1.2 | 1.33 |
| actin filament bundle | 1 | 1.76 | 1.07 | 1.13 | 1.08 | 1.49 | 1.28 | 1.15 |
| actin filament bundle assembly | 17 | 1.57 | -1.02 | 1.24 | -1.1 | 1.24 | 1.29 | 1.51 |
| actin filament capping | 2 | -1.38 | -1.03 | 2.18 | 1.01 | 1.59 | -1.39 | -1.04 |
| actin filament depolymerization | 4 | -1.06 | 1.03 | 1.27 | 1.14 | 1.25 | -1.37 | -1.31 |
| actin filament organization | 87 | 1.01 | 1.07 | 1.38 | 1.03 | 1.32 | 1.12 | 1.17 |
| actin filament polymerization | 6 | -1.34 | 1.04 | 1.42 | 1.14 | 1.28 | -1.56 | -1.16 |
| actin filament reorganization involved in cell cycle | 3 | -1.25 | 1.17 | 1.3 | 1.13 | 1.1 | -1.42 | -1.1 |
| actin filament-based movement | 2 | -1.84 | 1.42 | 2.86 | 1.0 | 1.74 | 1.92 | 1.21 |
| actin filament-based process | 163 | 1.17 | 1.03 | 1.35 | -1.03 | 1.3 | 1.31 | 1.17 |
| actin monomer binding | 1 | -3.23 | -1.14 | 1.86 | -1.09 | 2.26 | -4.44 | -1.1 |
| actin nucleation | 4 | -2.38 | 1.35 | 1.23 | 1.09 | 1.22 | -1.94 | 1.21 |
| actin polymerization or depolymerization | 10 | -1.07 | 1.03 | 1.37 | 1.11 | 1.28 | -1.26 | -1.14 |
| actin-dependent ATPase activity | 2 | -1.22 | 1.77 | 3.71 | -1.0 | 2.23 | 2.34 | 2.03 |
| actin-mediated cell contraction | 4 | -1.26 | 1.28 | 1.59 | 1.06 | 1.39 | 1.15 | 1.23 |
| actinin binding | 1 | 1.14 | -1.01 | 1.12 | 1.41 | 1.03 | -1.2 | -1.43 |
| activating transcription factor binding | 9 | 1.49 | -1.18 | -1.05 | -1.08 | 1.1 | 1.31 | 1.18 |
| activation of adenylate cyclase activity | 5 | 1.21 | 1.07 | 1.13 | 1.0 | 1.06 | 1.08 | -1.01 |
| activation of adenylate cyclase activity by dopamine receptor signaling pathway | 2 | -1.21 | 1.11 | -1.21 | 1.0 | -1.21 | -1.22 | -1.28 |
| activation of adenylate cyclase activity by G-protein signaling pathway | 3 | -1.05 | 1.08 | -1.04 | 1.0 | -1.08 | -1.13 | -1.16 |
| activation of adenylate cyclase activity by serotonin receptor signaling pathway | 1 | 1.27 | 1.02 | 1.28 | 1.01 | 1.16 | 1.03 | 1.05 |
| activation of anaphase-promoting complex activity | 1 | 1.0 | -1.01 | -1.14 | -1.09 | -1.19 | -1.12 | -1.06 |
| activation of anaphase-promoting complex activity involved in meiotic cell cycle | 1 | 1.0 | -1.01 | -1.14 | -1.09 | -1.19 | -1.12 | -1.06 |
| activation of cysteine-type endopeptidase activity | 13 | 1.0 | 1.15 | 1.25 | 1.21 | 1.45 | 1.21 | 1.07 |
| activation of cysteine-type endopeptidase activity involved in apoptotic process | 13 | 1.0 | 1.15 | 1.25 | 1.21 | 1.45 | 1.21 | 1.07 |
| activation of immune response | 1 | 1.17 | 1.46 | 1.63 | 1.36 | 1.42 | 1.78 | 1.19 |
| activation of JNKK activity | 2 | 1.23 | 1.27 | 1.56 | 1.2 | 1.54 | 1.23 | 1.3 |
| activation of JUN kinase activity | 2 | -1.08 | 1.31 | 1.72 | 1.2 | 1.5 | 1.32 | 1.54 |
| activation of MAPK activity | 7 | 1.11 | 1.21 | 1.54 | 1.12 | 1.37 | 2.0 | 1.14 |
| activation of MAPKK activity | 3 | 1.19 | 1.2 | 1.4 | 1.2 | 1.34 | 1.15 | 1.19 |
| activation of MAPKKK activity | 1 | -1.25 | 1.21 | 1.4 | 1.19 | 1.07 | 1.11 | 1.44 |
| activation of phospholipase C activity | 6 | 1.13 | 1.12 | 1.17 | 1.04 | 1.09 | 1.14 | 1.05 |
| activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 4 | 1.12 | 1.13 | 1.06 | 1.07 | 1.06 | 1.07 | 1.09 |
| activation of phospholipase C activity by serotonin receptor signaling pathway | 1 | 1.44 | 1.03 | -1.0 | 1.12 | 1.06 | 1.16 | -1.02 |
| activation of pro-apoptotic gene products | 1 | 1.78 | 1.11 | 1.56 | 1.24 | 1.76 | -1.03 | 1.11 |
| activation of protein kinase activity | 19 | 1.27 | 1.12 | 1.2 | 1.07 | 1.14 | 1.38 | 1.17 |
| activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway | 8 | 1.65 | 1.05 | -1.03 | -1.02 | -1.04 | 1.17 | 1.24 |
| activation of Rac GTPase activity | 2 | -1.11 | 1.35 | 2.32 | 1.27 | 2.42 | 1.41 | 1.46 |
| activation of Ras GTPase activity | 2 | -1.11 | 1.35 | 2.32 | 1.27 | 2.42 | 1.41 | 1.46 |
| activation of Rho GTPase activity | 2 | -1.11 | 1.35 | 2.32 | 1.27 | 2.42 | 1.41 | 1.46 |
| activation of store-operated calcium channel activity | 1 | 2.63 | 1.01 | 1.53 | -1.05 | 1.46 | 2.52 | 1.76 |
| activation of tryptophan 5-monooxygenase activity | 1 | 2.28 | 1.19 | 1.07 | -1.0 | 1.37 | 2.2 | 2.5 |
| active transmembrane transporter activity | 330 | -1.26 | -1.06 | -1.28 | -1.12 | -1.06 | 1.14 | -1.11 |
| activin binding | 2 | -1.14 | 1.57 | 1.93 | 1.23 | 1.67 | 1.43 | 1.4 |
| activin receptor activity, type I | 1 | -1.85 | 1.82 | 2.01 | 1.27 | 1.8 | 1.64 | 1.57 |
| activin receptor complex | 2 | -1.14 | 1.57 | 1.93 | 1.23 | 1.67 | 1.43 | 1.4 |
| activin receptor signaling pathway | 3 | -2.1 | 2.02 | -1.27 | -1.55 | -1.26 | -1.31 | 1.66 |
| activin-activated receptor activity | 2 | -1.14 | 1.57 | 1.93 | 1.23 | 1.67 | 1.43 | 1.4 |
| actomyosin | 1 | 1.76 | 1.07 | 1.13 | 1.08 | 1.49 | 1.28 | 1.15 |
| actomyosin contractile ring | 4 | -1.06 | 1.15 | 1.51 | 1.14 | 1.77 | 1.47 | 1.16 |
| actomyosin structure organization | 47 | 1.76 | -1.18 | 1.14 | -1.18 | 1.17 | 1.52 | 1.04 |
| acute inflammatory response | 3 | -1.45 | 1.14 | 1.29 | 1.15 | 1.43 | -1.36 | 1.17 |
| acute inflammatory response to antigenic stimulus | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
| acute-phase response | 1 | 1.84 | 1.22 | 1.59 | 1.61 | 1.65 | 1.41 | 1.04 |
| acyl carnitine transport | 2 | 1.34 | 1.32 | -1.91 | 1.22 | 1.14 | -1.7 | -1.23 |
| acyl carnitine transporter activity | 2 | 1.23 | 1.21 | -1.11 | 1.11 | 1.06 | -1.22 | -1.1 |
| acyl carrier activity | 6 | 1.59 | 1.03 | 1.12 | 1.01 | 1.14 | 1.4 | 1.17 |
| acyl-[acyl-carrier-protein] hydrolase activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
| acyl-CoA biosynthetic process | 5 | 2.3 | 1.04 | 1.28 | 1.15 | 1.53 | 1.22 | 1.09 |
| acyl-CoA dehydrogenase activity | 15 | -1.17 | 1.11 | -1.37 | 1.1 | 1.1 | -1.79 | -1.3 |
| acyl-CoA delta11-desaturase activity | 1 | -3.53 | -3.34 | -2.71 | -4.29 | -3.06 | -2.31 | 4.71 |
| acyl-CoA desaturase activity | 8 | -1.57 | -1.03 | -1.33 | 1.02 | -1.14 | -1.74 | 1.05 |
| acyl-CoA hydrolase activity | 2 | 1.13 | 1.03 | -1.08 | 1.05 | 1.02 | 1.1 | -1.09 |
| acyl-CoA metabolic process | 6 | 2.01 | 1.03 | 1.27 | 1.12 | 1.42 | 1.33 | 1.06 |
| acyl-CoA N-acyltransferase activity | 1 | 1.2 | 1.15 | 1.75 | 1.03 | 1.4 | 1.08 | 1.36 |
| acyl-CoA oxidase activity | 6 | -2.19 | 1.03 | -1.7 | 1.08 | 1.14 | -3.66 | -1.47 |
| acylglycerol biosynthetic process | 3 | 2.65 | 1.06 | 2.5 | -1.19 | 1.69 | 1.64 | 1.56 |
| acylglycerol catabolic process | 2 | 1.6 | 1.03 | -1.14 | -1.01 | 1.9 | -1.45 | -1.11 |
| acylglycerol homeostasis | 1 | 1.16 | 1.22 | 2.13 | 1.14 | 1.8 | 2.14 | 1.55 |
| acylglycerol metabolic process | 10 | 1.74 | -1.01 | 1.02 | -1.04 | 1.58 | -1.11 | -1.1 |
| acylglycerol O-acyltransferase activity | 7 | -1.48 | -1.12 | 1.19 | 1.18 | 2.2 | -2.06 | -1.75 |
| acylphosphatase activity | 6 | 1.57 | 1.0 | -1.02 | 1.01 | -1.1 | 1.04 | -1.12 |
| Ada2/Gcn5/Ada3 transcription activator complex | 8 | 1.4 | 1.19 | 1.36 | 1.24 | 1.39 | 1.07 | 1.22 |
| adaptation of rhodopsin mediated signaling | 4 | -1.08 | 1.14 | 1.07 | 1.08 | 1.11 | -1.0 | -1.04 |
| adaptation of signaling pathway | 4 | -1.08 | 1.14 | 1.07 | 1.08 | 1.11 | -1.0 | -1.04 |
| adaptive immune response | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
| adenine biosynthetic process | 1 | 1.17 | 1.37 | 1.23 | 1.24 | 1.3 | 1.33 | -1.5 |
| adenine metabolic process | 1 | 1.17 | 1.37 | 1.23 | 1.24 | 1.3 | 1.33 | -1.5 |
| adenine nucleotide transport | 2 | -1.19 | 1.19 | 1.41 | 1.1 | 1.28 | 1.45 | -1.24 |
| adenine phosphoribosyltransferase activity | 1 | 1.17 | 1.37 | 1.23 | 1.24 | 1.3 | 1.33 | -1.5 |
| adenine salvage | 1 | 1.17 | 1.37 | 1.23 | 1.24 | 1.3 | 1.33 | -1.5 |
| adenosine deaminase activity | 8 | -1.69 | 1.1 | 1.06 | -1.03 | -1.09 | 1.15 | -1.16 |
| adenosine kinase activity | 4 | 1.16 | 1.08 | -1.11 | 1.18 | 1.12 | 1.14 | -1.1 |
| adenosine to inosine editing | 1 | 1.13 | 1.14 | 1.55 | 1.01 | 1.4 | 2.0 | 1.26 |
| adenosylhomocysteinase activity | 3 | -2.93 | -1.82 | -1.21 | -1.07 | 1.22 | 1.86 | -1.16 |
| adenosylmethionine decarboxylase activity | 1 | 1.82 | 1.07 | 1.08 | 1.22 | 1.03 | 1.75 | -1.05 |
| adenyl nucleotide binding | 654 | 1.06 | 1.1 | 1.17 | 1.09 | 1.22 | 1.18 | 1.09 |
| adenyl ribonucleotide binding | 653 | 1.06 | 1.1 | 1.17 | 1.09 | 1.22 | 1.18 | 1.1 |
| adenyl-nucleotide exchange factor activity | 1 | -1.14 | 1.21 | -1.05 | 1.17 | 1.0 | -1.29 | -1.36 |
| adenylate cyclase activity | 12 | 1.43 | 1.1 | 1.07 | -1.04 | 1.13 | 1.5 | 1.22 |
| adenylate kinase activity | 6 | 1.61 | -1.18 | 1.01 | 1.04 | 1.05 | 1.04 | -1.33 |
| adenylosuccinate synthase activity | 1 | 2.08 | 1.19 | 1.56 | -1.1 | -1.15 | 1.56 | -1.05 |
| adenylylsulfate kinase activity | 1 | -2.63 | 1.06 | 1.41 | 1.07 | 1.11 | -1.64 | -1.02 |
| adenylyltransferase activity | 11 | -1.05 | 1.19 | 1.21 | 1.12 | 1.08 | -1.03 | 1.08 |
| adherens junction | 58 | 1.23 | 1.15 | 1.4 | 1.04 | 1.4 | 1.35 | 1.31 |
| adherens junction assembly | 2 | -1.2 | -1.04 | -1.19 | 1.02 | -1.08 | -1.21 | -1.15 |
| adherens junction maintenance | 7 | -1.01 | 1.13 | 1.67 | 1.07 | 1.42 | 1.13 | -1.02 |
| adherens junction organization | 12 | 1.06 | 1.11 | 1.42 | 1.06 | 1.32 | 1.17 | 1.09 |
| adipokinetic hormone binding | 2 | 1.14 | 1.03 | 1.06 | 1.02 | -1.01 | -1.0 | -1.03 |
| adipokinetic hormone receptor activity | 2 | 1.14 | 1.03 | 1.06 | 1.02 | -1.01 | -1.0 | -1.03 |
| adipokinetic hormone receptor binding | 1 | 2.14 | -13.11 | -13.63 | -12.76 | -16.87 | -14.38 | 5.61 |
| ADP biosynthetic process | 2 | -1.29 | -1.01 | -1.04 | 1.37 | 1.42 | -2.05 | -1.57 |
| ADP metabolic process | 2 | -1.29 | -1.01 | -1.04 | 1.37 | 1.42 | -2.05 | -1.57 |
| ADP transport | 2 | -1.19 | 1.19 | 1.41 | 1.1 | 1.28 | 1.45 | -1.24 |
| ADP-D-ribose binding | 1 | 1.71 | 1.0 | 1.2 | 1.14 | 1.43 | 1.37 | 1.01 |
| adrenergic receptor activity | 2 | -1.09 | 1.2 | -1.08 | -1.0 | -1.18 | -1.21 | -1.07 |
| adrenergic receptor signaling pathway | 2 | -1.09 | 1.2 | -1.08 | -1.0 | -1.18 | -1.21 | -1.07 |
| adult behavior | 100 | 1.26 | -1.03 | 1.14 | -1.07 | 1.14 | 1.22 | 1.28 |
| adult chitin-based cuticle development | 10 | 1.01 | -1.17 | -1.08 | -1.07 | -1.12 | -1.07 | 1.3 |
| adult chitin-based cuticle pattern formation | 1 | -1.38 | -1.23 | -1.19 | -1.18 | -1.36 | -1.47 | -1.32 |
| adult chitin-containing cuticle pigmentation | 5 | 1.15 | -1.36 | -1.08 | -1.2 | -1.43 | 1.07 | 1.86 |
| adult feeding behavior | 7 | 1.32 | -1.86 | -1.97 | -2.12 | -2.07 | -1.51 | 2.24 |
| adult locomotory behavior | 50 | 1.11 | 1.02 | 1.21 | 1.0 | 1.17 | 1.25 | 1.14 |
| adult somatic muscle development | 10 | 1.25 | 1.07 | 1.59 | 1.07 | 1.35 | 1.16 | 1.08 |
| adult walking behavior | 9 | -1.95 | 1.22 | 1.15 | 1.1 | 1.23 | -1.39 | 1.15 |
| aerobic respiration | 37 | -1.01 | 1.07 | 1.26 | -1.07 | 1.11 | 1.57 | -1.08 |
| age-dependent general metabolic decline | 1 | -1.1 | 1.09 | 1.19 | 1.01 | 1.01 | 1.19 | 1.25 |
| age-dependent response to oxidative stress | 1 | -1.1 | 1.09 | 1.19 | 1.01 | 1.01 | 1.19 | 1.25 |
| aggressive behavior | 44 | 1.19 | 1.05 | 1.23 | -1.02 | 1.15 | 1.61 | 1.24 |
| aging | 114 | 1.25 | 1.12 | 1.11 | -1.02 | 1.16 | 1.37 | 1.25 |
| alanine biosynthetic process | 1 | 1.7 | 1.2 | 1.13 | 1.08 | -1.16 | -1.08 | 1.29 |
| alanine metabolic process | 1 | 1.7 | 1.2 | 1.13 | 1.08 | -1.16 | -1.08 | 1.29 |
| alanine-glyoxylate transaminase activity | 3 | -2.83 | 1.14 | -4.47 | -1.13 | -1.51 | -1.62 | 1.13 |
| alanine-oxo-acid transaminase activity | 1 | -2.33 | 1.13 | 1.14 | 1.09 | 1.76 | 1.77 | -1.09 |
| alanine-tRNA ligase activity | 3 | -1.05 | 1.37 | 1.07 | 1.17 | 1.09 | 1.18 | 1.07 |
| alanyl-tRNA aminoacylation | 3 | -1.05 | 1.37 | 1.07 | 1.17 | 1.09 | 1.18 | 1.07 |
| alcohol binding | 1 | 1.12 | 1.0 | 1.13 | 1.06 | 1.1 | -1.01 | -1.1 |
| alcohol biosynthetic process | 14 | 1.09 | -1.23 | -1.05 | -1.2 | 1.02 | 1.19 | 1.3 |
| alcohol catabolic process | 39 | 1.48 | 1.03 | -1.37 | -1.1 | -1.08 | 1.21 | 1.22 |
| alcohol dehydrogenase (NAD) activity | 5 | 1.66 | -1.09 | -1.8 | -1.39 | -1.21 | 1.37 | 1.27 |
| alcohol dehydrogenase (NADP+) activity | 7 | 1.25 | 1.15 | -1.37 | -1.18 | -1.21 | 1.14 | 1.22 |
| alcohol metabolic process | 137 | -1.15 | -1.03 | -1.35 | 1.01 | -1.01 | -1.18 | -1.15 |
| alcohol transmembrane transporter activity | 2 | -1.44 | 1.12 | -1.06 | 1.14 | 1.1 | -1.2 | 1.33 |
| aldehyde catabolic process | 1 | 1.1 | -1.81 | -2.08 | -1.81 | -1.6 | 3.21 | -1.83 |
| aldehyde dehydrogenase (NAD) activity | 3 | -1.65 | 1.15 | -1.65 | 1.05 | -1.41 | -1.9 | -1.31 |
| aldehyde dehydrogenase [NAD(P)+] activity | 1 | 1.67 | -1.24 | -1.26 | 1.36 | 2.03 | -1.43 | 1.25 |
| aldehyde-lyase activity | 4 | -1.25 | 1.0 | -1.2 | 1.35 | 1.18 | -1.18 | -1.45 |
| alditol catabolic process | 2 | 1.2 | 1.12 | -1.49 | 1.16 | 1.79 | -1.21 | -1.08 |
| alditol metabolic process | 16 | -1.18 | 1.1 | -1.05 | 1.11 | 1.01 | -1.33 | -1.11 |
| alditol:NADP+ 1-oxidoreductase activity | 6 | -1.18 | 1.24 | -1.3 | -1.16 | -1.25 | -1.07 | 1.15 |
| aldo-keto reductase (NADP) activity | 7 | 1.25 | 1.15 | -1.37 | -1.18 | -1.21 | 1.14 | 1.22 |
| aldose 1-epimerase activity | 3 | -1.46 | 1.17 | -1.47 | -1.07 | 1.13 | -1.58 | -1.03 |
| alkali metal ion binding | 7 | 1.18 | 1.01 | 1.0 | -1.0 | -1.04 | 1.2 | -1.0 |
| alkaline phosphatase activity | 13 | -5.32 | -1.81 | -4.2 | -1.19 | -1.19 | -4.42 | -4.05 |
| alkane 1-monooxygenase activity | 1 | 1.6 | 1.35 | -1.72 | -1.6 | -1.17 | -1.33 | 1.5 |
| alkane biosynthetic process | 1 | 1.08 | 1.05 | 1.26 | 1.07 | 1.31 | 1.33 | 1.1 |
| alkene biosynthetic process | 1 | -1.74 | 1.11 | -2.01 | 1.51 | 1.27 | -1.87 | -1.55 |
| alkyl sulfatase activity | 1 | 2.4 | 1.23 | 1.72 | -1.4 | 3.44 | 4.52 | 1.64 |
| alkylglycerone-phosphate synthase activity | 1 | 5.42 | -21.99 | -24.45 | -20.82 | -3.99 | -1.47 | 6.54 |
| all | 9919 | 1.03 | -1.01 | 1.01 | 1.01 | 1.05 | 1.03 | 1.01 |
| allantoin biosynthetic process | 1 | 3.87 | -2.08 | -2.11 | -2.0 | -1.26 | -1.05 | -1.64 |
| allantoin catabolic process | 1 | 2.85 | -1.01 | 1.16 | 1.03 | -1.08 | 1.74 | -1.1 |
| allantoin metabolic process | 2 | 3.32 | -1.45 | -1.35 | -1.39 | -1.17 | 1.29 | -1.34 |
| allantoinase activity | 1 | 2.85 | -1.01 | 1.16 | 1.03 | -1.08 | 1.74 | -1.1 |
| allatostatin receptor activity | 5 | -1.14 | -1.08 | 1.25 | -1.02 | 1.16 | 1.25 | -1.31 |
| alpha DNA polymerase:primase complex | 4 | -1.1 | 1.07 | 1.15 | 1.07 | 1.18 | 1.06 | -1.25 |
| alpha,alpha-trehalase activity | 3 | -2.73 | 1.23 | -2.68 | 1.17 | -1.22 | -2.41 | 1.01 |
| alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity | 1 | 1.32 | -4.96 | -6.02 | -4.98 | -1.62 | 7.64 | -3.94 |
| alpha-(1->3)-fucosyltransferase activity | 4 | -1.8 | 1.18 | 1.3 | 1.19 | 1.58 | -1.36 | -1.16 |
| alpha-(1->6)-fucosyltransferase activity | 1 | 1.63 | 1.17 | -1.53 | -1.05 | -1.49 | 4.17 | 1.53 |
| alpha-1,2-mannosyltransferase activity | 1 | -1.58 | 1.15 | -1.08 | 1.11 | -1.2 | -1.77 | 1.49 |
| alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity | 1 | 3.18 | 1.02 | 1.47 | 1.11 | 1.44 | 4.09 | 2.36 |
| alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | 2 | 1.98 | -1.1 | 1.19 | -1.09 | 1.23 | 2.85 | 1.26 |
| alpha-1,4-N-acetylgalactosaminyltransferase activity | 1 | 3.56 | 1.12 | 1.2 | 1.23 | 1.49 | 1.56 | 1.46 |
| alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity | 1 | 3.56 | -1.43 | -1.34 | -1.25 | -1.02 | 7.35 | 1.28 |
| alpha-1,6-mannosyltransferase activity | 1 | 1.2 | 1.3 | 1.28 | 1.05 | 1.27 | 1.14 | 1.6 |
| alpha-actinin binding | 1 | 1.14 | -1.01 | 1.12 | 1.41 | 1.03 | -1.2 | -1.43 |
| alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity | 2 | -1.07 | -1.07 | -1.18 | -1.06 | -1.13 | -1.05 | -1.13 |
| alpha-amylase activity | 2 | -34.84 | -2.22 | -3.89 | 2.13 | -10.58 | -52.06 | -2.46 |
| alpha-catenin binding | 1 | 1.17 | 1.11 | 1.06 | 1.15 | 1.09 | 1.09 | 1.68 |
| alpha-galactosidase activity | 1 | -4.17 | 1.11 | -1.19 | -1.11 | -1.3 | -2.49 | 3.87 |
| alpha-glucosidase activity | 13 | -7.82 | -1.11 | -3.92 | 1.01 | -2.19 | -4.92 | -2.34 |
| alpha-glucoside transport | 2 | 1.24 | -2.16 | -1.19 | -2.0 | -1.13 | 3.38 | 1.3 |
| alpha-heterochromatin | 1 | 1.02 | 1.05 | 1.18 | 1.16 | 1.33 | 1.09 | 1.01 |
| alpha-ketoglutarate transport | 3 | -1.11 | -1.06 | 1.14 | -1.03 | -1.15 | 1.61 | -1.21 |
| alpha-L-fucosidase activity | 1 | -1.1 | -1.19 | -1.53 | -1.9 | -1.86 | -1.28 | 7.99 |
| alpha-mannosidase activity | 9 | -14.64 | -1.14 | -7.39 | 1.54 | -1.15 | -14.33 | -25.61 |
| alpha-methylacyl-CoA racemase activity | 1 | 4.0 | -1.32 | -1.02 | 1.57 | 2.33 | 1.69 | -1.27 |
| alpha-N-acetylgalactosaminidase activity | 1 | 1.06 | -1.01 | -1.01 | 1.04 | -1.07 | -1.04 | 1.13 |
| alpha-N-acetylglucosaminidase activity | 1 | -1.03 | -1.29 | -2.28 | -2.21 | -1.93 | 20.24 | 3.19 |
| alternative nuclear mRNA splicing, via spliceosome | 1 | 1.52 | 1.27 | 1.61 | 1.3 | 1.51 | 2.77 | 1.58 |
| ameboidal cell migration | 35 | 1.62 | -1.01 | 1.31 | -1.06 | 1.21 | 1.46 | 1.11 |
| amidase activity | 1 | 1.54 | -1.32 | 2.9 | 1.39 | -1.83 | -6.19 | -2.79 |
| amide biosynthetic process | 3 | -2.21 | -1.28 | -2.94 | -1.05 | 1.16 | -1.62 | -1.65 |
| amide transport | 1 | 1.41 | 1.17 | -1.02 | 1.18 | -1.05 | -1.09 | 1.18 |
| amidine-lyase activity | 2 | -3.73 | 1.28 | -2.46 | 1.25 | 1.21 | -1.91 | 1.03 |
| amidophosphoribosyltransferase activity | 2 | 1.11 | 1.02 | -1.15 | -1.13 | -1.43 | 1.89 | -1.09 |
| amine binding | 16 | -1.41 | -1.08 | -1.46 | 1.15 | 1.12 | -1.1 | -1.47 |
| amine biosynthetic process | 54 | 1.05 | -1.02 | -1.24 | -1.05 | -1.1 | 1.19 | 1.08 |
| amine catabolic process | 29 | -1.04 | -1.07 | -1.13 | -1.1 | -1.04 | 1.35 | -1.08 |
| amine metabolic process | 302 | -1.22 | -1.19 | -1.33 | -1.18 | -1.18 | -1.09 | 1.09 |
| amine transmembrane transporter activity | 58 | -1.3 | -1.08 | -1.61 | -1.23 | -1.04 | -1.08 | -1.11 |
| amine transport | 43 | -1.38 | -1.14 | -1.77 | -1.23 | -1.02 | -1.05 | -1.16 |
| amine-lyase activity | 2 | -1.04 | 1.14 | -1.34 | 1.32 | 1.5 | -1.36 | 1.15 |
| amino acid activation | 42 | -1.06 | 1.25 | 1.26 | 1.14 | 1.18 | 1.05 | 1.08 |
| amino acid activation for nonribosomal peptide biosynthetic process | 1 | 1.36 | 1.09 | 1.02 | -1.03 | -1.16 | 1.04 | 1.01 |
| amino acid adenylylation by nonribosomal peptide synthase | 1 | 1.36 | 1.09 | 1.02 | -1.03 | -1.16 | 1.04 | 1.01 |
| amino acid binding | 15 | -1.42 | -1.07 | -1.49 | 1.17 | 1.15 | -1.1 | -1.49 |
| amino acid import | 4 | -2.33 | 1.09 | -2.25 | -1.01 | 1.43 | -1.47 | -1.72 |
| amino acid kinase activity | 4 | -2.33 | 1.24 | -1.02 | 1.02 | -1.11 | -1.42 | -1.1 |
| amino acid salvage | 1 | 1.92 | 1.16 | 1.15 | 1.28 | 1.06 | 2.87 | -1.21 |
| amino acid transmembrane transport | 30 | -1.61 | -1.12 | -1.51 | -1.16 | -1.02 | -1.08 | -1.1 |
| amino acid transmembrane transporter activity | 53 | -1.39 | -1.07 | -1.67 | -1.24 | -1.03 | -1.11 | -1.1 |
| amino acid transport | 39 | -1.51 | -1.14 | -1.83 | -1.24 | 1.0 | -1.08 | -1.16 |
| amino sugar biosynthetic process | 1 | 1.0 | -1.04 | -1.09 | -1.07 | -1.02 | 1.03 | -1.14 |
| amino sugar metabolic process | 9 | 1.34 | 1.24 | 1.13 | 1.09 | 1.26 | 1.2 | 1.12 |
| aminoacyl-tRNA hydrolase activity | 3 | 1.72 | -1.02 | 1.14 | 1.1 | 1.0 | 1.49 | -1.08 |
| aminoacyl-tRNA ligase activity | 40 | -1.07 | 1.26 | 1.26 | 1.14 | 1.18 | 1.05 | 1.09 |
| aminoacyl-tRNA synthetase multienzyme complex | 3 | 1.11 | 1.2 | 1.09 | 1.15 | 1.05 | -1.07 | 1.06 |
| aminoacylase activity | 6 | -1.72 | -1.86 | -1.07 | -1.63 | 1.29 | -1.6 | -1.71 |
| aminoglycan biosynthetic process | 15 | 1.36 | 1.11 | 1.12 | 1.03 | 1.14 | 1.41 | 1.3 |
| aminoglycan catabolic process | 29 | -1.22 | -1.95 | -2.17 | -1.68 | -1.71 | -1.1 | 1.4 |
| aminoglycan metabolic process | 120 | -1.64 | -1.63 | -1.78 | -1.48 | -1.53 | -1.5 | 1.27 |
| aminomethyltransferase activity | 4 | 1.27 | 1.14 | 1.17 | 1.01 | -1.01 | 1.6 | 1.08 |
| aminopeptidase activity | 36 | -2.28 | -1.12 | -1.52 | 1.05 | 1.14 | -1.43 | -1.98 |
| ammonia ligase activity | 2 | 1.91 | -1.99 | 2.01 | -1.44 | 1.52 | -1.73 | -1.25 |
| ammonia-lyase activity | 1 | -3.81 | -2.74 | -2.14 | -1.15 | 11.07 | -1.69 | -3.46 |
| ammonium transmembrane transport | 1 | -1.13 | -1.02 | -1.13 | -1.06 | -1.15 | -1.01 | -1.16 |
| ammonium transmembrane transporter activity | 1 | -1.13 | -1.02 | -1.13 | -1.06 | -1.15 | -1.01 | -1.16 |
| ammonium transport | 1 | -1.13 | -1.02 | -1.13 | -1.06 | -1.15 | -1.01 | -1.16 |
| amnioserosa formation | 5 | 1.56 | -1.06 | 1.14 | -1.19 | -1.08 | -1.04 | 1.05 |
| amnioserosa maintenance | 5 | -1.1 | 1.14 | 1.38 | 1.06 | 1.23 | -1.08 | 1.88 |
| AMP binding | 1 | 3.48 | 1.38 | -1.48 | 1.01 | -2.42 | 1.73 | 1.65 |
| AMP deaminase activity | 1 | 1.21 | 1.11 | 1.3 | -1.14 | 1.24 | 3.4 | 1.06 |
| AMP-activated protein kinase activity | 3 | 1.06 | 1.32 | 1.11 | 1.03 | -1.06 | 1.31 | 1.11 |
| AMP-activated protein kinase complex | 1 | 1.2 | 1.33 | 1.18 | -1.01 | -1.15 | 1.3 | 1.08 |
| amylase activity | 2 | -34.84 | -2.22 | -3.89 | 2.13 | -10.58 | -52.06 | -2.46 |
| amylo-alpha-1,6-glucosidase activity | 1 | 1.91 | -1.57 | -1.98 | 1.36 | -1.16 | 2.47 | 1.07 |
| amyloid precursor protein metabolic process | 1 | 1.02 | 1.3 | 1.25 | 1.11 | 1.03 | 1.74 | 1.33 |
| anaerobic respiration | 1 | 1.08 | 1.05 | 1.26 | 1.07 | 1.31 | 1.33 | 1.1 |
| analia development | 6 | -1.15 | -1.64 | -1.26 | 1.2 | 1.4 | -1.24 | -1.79 |
| anaphase | 25 | 1.25 | 1.11 | 1.26 | 1.14 | 1.31 | 1.3 | 1.1 |
| anaphase-promoting complex | 10 | 1.4 | 1.11 | 1.22 | 1.13 | 1.2 | 1.12 | 1.1 |
| anaphase-promoting complex binding | 1 | 1.0 | -1.01 | -1.14 | -1.09 | -1.19 | -1.12 | -1.06 |
| anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 4 | 1.26 | 1.09 | 1.04 | 1.07 | 1.05 | -1.03 | -1.01 |
| anatomical structure development | 2169 | 1.15 | 1.05 | 1.16 | 1.04 | 1.18 | 1.2 | 1.13 |
| anatomical structure formation involved in morphogenesis | 388 | 1.14 | 1.06 | 1.21 | 1.03 | 1.22 | 1.22 | 1.17 |
| anatomical structure homeostasis | 48 | 1.3 | 1.03 | 1.25 | 1.01 | 1.27 | 1.36 | 1.27 |
| anatomical structure maturation | 3 | 3.11 | -1.4 | 1.27 | -1.39 | 1.24 | 4.46 | 1.69 |
| anatomical structure morphogenesis | 1160 | 1.14 | 1.06 | 1.19 | 1.02 | 1.21 | 1.23 | 1.19 |
| anchored to membrane | 3 | 3.1 | -2.01 | -3.22 | -2.43 | -1.37 | 2.44 | 1.37 |
| anchored to plasma membrane | 3 | 3.1 | -2.01 | -3.22 | -2.43 | -1.37 | 2.44 | 1.37 |
| anchoring junction | 59 | 1.24 | 1.15 | 1.4 | 1.04 | 1.4 | 1.33 | 1.31 |
| androgen metabolic process | 1 | 1.03 | -1.04 | 1.2 | -1.01 | 1.0 | 2.11 | -1.07 |
| anesthesia-resistant memory | 8 | 1.01 | -1.16 | -1.04 | -1.21 | -1.14 | 1.22 | 1.39 |
| anion binding | 1 | 1.12 | 1.0 | 1.13 | 1.06 | 1.1 | -1.01 | -1.1 |
| anion channel activity | 23 | -1.01 | 1.02 | -1.01 | -1.14 | -1.11 | 1.24 | 1.08 |
| anion exchanger adaptor activity | 1 | -1.15 | 1.11 | 1.03 | 1.13 | 1.14 | 1.45 | 1.27 |
| anion transmembrane transporter activity | 90 | -1.43 | -1.05 | -1.42 | -1.25 | -1.3 | 1.08 | -1.17 |
| anion transmembrane-transporting ATPase activity | 1 | 1.35 | 1.29 | 1.36 | 1.08 | 1.19 | 1.34 | 1.11 |
| anion transport | 43 | -1.18 | -1.09 | -1.23 | -1.24 | -1.09 | 1.32 | -1.06 |
| anion:anion antiporter activity | 7 | -1.5 | -1.45 | 1.6 | -1.5 | -1.11 | 1.16 | -1.09 |
| anion:cation symporter activity | 36 | -2.03 | -1.02 | -2.27 | -1.32 | -1.7 | -1.35 | -1.62 |
| ankyrin binding | 2 | -1.35 | 1.17 | 1.37 | -1.02 | 1.05 | 1.36 | 1.56 |
| annulate lamellae | 1 | -1.39 | 1.32 | -1.25 | 1.42 | 1.03 | -1.29 | -1.2 |
| antennal development | 21 | -1.03 | 1.02 | 1.12 | 1.04 | 1.07 | 1.26 | 1.08 |
| antennal joint development | 4 | -1.02 | 1.09 | 1.04 | 1.04 | -1.02 | 1.19 | -1.03 |
| antennal joint morphogenesis | 1 | 1.21 | 1.22 | 1.16 | 1.1 | 1.2 | 1.57 | 1.03 |
| antennal morphogenesis | 13 | -1.02 | 1.09 | 1.27 | 1.06 | 1.16 | 1.4 | 1.12 |
| anterior commissure morphogenesis | 2 | -1.33 | -1.42 | -1.06 | 1.28 | 1.22 | -1.65 | -2.16 |
| anterior head development | 9 | 1.09 | -1.1 | 1.06 | 1.06 | -1.02 | -1.13 | -1.01 |
| anterior head segmentation | 9 | 1.09 | -1.1 | 1.06 | 1.06 | -1.02 | -1.13 | -1.01 |
| anterior Malpighian tubule development | 12 | -1.05 | -1.01 | 1.18 | -1.15 | 1.13 | 1.62 | 1.06 |
| anterior midgut development | 3 | -1.08 | 1.25 | 1.25 | -1.4 | 1.12 | 1.13 | 1.58 |
| anterior midgut invagination | 3 | 1.4 | 1.11 | 1.46 | 1.17 | 1.72 | 1.88 | 1.31 |
| anterior region determination | 3 | 1.62 | -1.05 | 1.0 | -1.14 | -1.1 | 1.06 | -1.02 |
| anterior/posterior axis specification | 120 | 1.19 | 1.06 | 1.26 | 1.05 | 1.25 | 1.26 | 1.2 |
| anterior/posterior axis specification, embryo | 114 | 1.21 | 1.09 | 1.29 | 1.04 | 1.25 | 1.28 | 1.24 |
| anterior/posterior axis specification, follicular epithelium | 1 | 8.32 | -1.09 | 1.22 | 1.02 | 1.27 | 3.95 | 1.61 |
| anterior/posterior lineage restriction, imaginal disc | 4 | 1.14 | -1.2 | 1.12 | 1.11 | 1.19 | -1.1 | -1.24 |
| anterior/posterior pattern specification | 147 | 1.2 | 1.04 | 1.2 | 1.01 | 1.24 | 1.3 | 1.21 |
| anterior/posterior pattern specification, imaginal disc | 20 | 1.23 | -1.26 | 1.02 | -1.03 | 1.24 | 1.42 | -1.03 |
| anterograde axon cargo transport | 4 | 1.14 | 1.18 | 1.17 | 1.17 | 1.3 | 1.25 | 1.03 |
| anterograde synaptic vesicle transport | 3 | -1.11 | 1.21 | 1.44 | 1.19 | 1.33 | 1.23 | 1.39 |
| anti-apoptosis | 18 | 1.77 | 1.02 | 1.32 | -1.0 | 1.46 | 1.51 | 1.52 |
| antibacterial humoral response | 22 | 1.72 | -1.69 | -1.59 | -1.57 | -1.23 | 1.37 | 1.27 |
| antibiotic biosynthetic process | 1 | -1.31 | -1.76 | 1.72 | 1.22 | 1.97 | 3.11 | 1.28 |
| antibiotic metabolic process | 1 | -1.31 | -1.76 | 1.72 | 1.22 | 1.97 | 3.11 | 1.28 |
| antifungal humoral response | 8 | 4.25 | -1.39 | -1.37 | -1.5 | -1.09 | 3.13 | 1.41 |
| antifungal peptide production | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
| antigen binding | 1 | -1.71 | -1.18 | -1.3 | -1.15 | -1.23 | -1.3 | 1.07 |
| antimicrobial humoral response | 59 | 1.29 | -1.22 | -1.15 | -1.21 | 1.01 | 1.23 | 1.27 |
| antimicrobial peptide production | 2 | -1.54 | 1.11 | 1.81 | 1.12 | 1.7 | 3.17 | 1.43 |
| antioxidant activity | 35 | 1.06 | 1.04 | -1.09 | -1.06 | -1.08 | -1.08 | 1.01 |
| antiporter activity | 25 | -1.4 | 1.02 | 1.06 | -1.09 | -1.06 | 1.2 | -1.02 |
| AP-1 adaptor complex | 1 | -1.46 | 1.16 | 1.32 | 1.12 | 1.05 | 1.44 | 1.08 |
| AP-2 adaptor complex binding | 1 | 1.51 | 1.33 | 2.01 | 1.25 | 1.81 | 2.91 | 1.9 |
| AP-3 adaptor complex | 1 | 1.85 | 1.2 | 1.21 | 1.06 | 1.07 | 1.4 | 1.37 |
| AP-type membrane coat adaptor complex | 9 | -1.11 | 1.2 | 1.31 | 1.16 | 1.2 | 1.14 | 1.2 |
| apical constriction | 4 | -1.26 | 1.28 | 1.59 | 1.06 | 1.39 | 1.15 | 1.23 |
| apical cortex | 27 | -1.0 | 1.23 | 1.46 | 1.07 | 1.36 | 1.19 | 1.13 |
| apical junction assembly | 33 | 2.06 | -1.11 | 1.37 | -1.16 | 1.26 | 2.36 | 1.49 |
| apical junction complex | 45 | 1.96 | -1.09 | 1.26 | -1.14 | 1.29 | 2.5 | 1.48 |
| apical part of cell | 62 | 1.31 | 1.12 | 1.35 | 1.0 | 1.28 | 1.5 | 1.32 |
| apical plasma membrane | 27 | 1.33 | 1.11 | 1.29 | 1.04 | 1.28 | 1.55 | 1.44 |
| apical protein localization | 9 | -1.03 | 1.16 | 1.11 | 1.05 | 1.43 | 1.01 | 1.44 |
| apicolateral plasma membrane | 50 | 1.77 | -1.05 | 1.29 | -1.11 | 1.27 | 2.3 | 1.5 |
| apocarotenoid metabolic process | 2 | 1.02 | 1.01 | 1.08 | 1.02 | -1.08 | 1.12 | -1.06 |
| apoptosis in response to endoplasmic reticulum stress | 1 | -1.56 | 1.12 | -1.6 | -1.09 | -1.49 | -1.56 | -1.26 |
| apoptotic cell clearance | 8 | 1.13 | -1.17 | 1.05 | -1.1 | 1.15 | 1.39 | 1.06 |
| apoptotic nuclear change | 3 | 1.86 | 1.09 | 1.48 | 1.14 | 1.43 | 1.6 | 1.67 |
| apoptotic process | 69 | 1.05 | 1.06 | 1.22 | 1.08 | 1.24 | -1.05 | 1.11 |
| apoptotic protease activator activity | 3 | 1.67 | 1.11 | 1.24 | 1.1 | 1.19 | 1.2 | 1.4 |
| appendage development | 238 | 1.25 | 1.06 | 1.22 | 1.01 | 1.29 | 1.33 | 1.3 |
| appendage morphogenesis | 236 | 1.25 | 1.06 | 1.22 | 1.01 | 1.29 | 1.34 | 1.3 |
| appendage segmentation | 20 | -1.29 | 1.07 | -1.1 | -1.14 | 1.65 | 1.34 | 1.29 |
| apposition of dorsal and ventral imaginal disc-derived wing surfaces | 17 | 1.92 | 1.04 | 1.15 | -1.07 | 1.24 | 1.93 | 1.28 |
| aralkylamine N-acetyltransferase activity | 1 | -8.98 | 1.77 | -2.05 | -1.02 | -2.08 | -14.22 | 1.22 |
| ARF GTPase activator activity | 9 | -1.07 | 1.11 | 1.17 | 1.02 | 1.17 | -1.02 | 1.45 |
| ARF guanyl-nucleotide exchange factor activity | 6 | -1.22 | 1.21 | 1.27 | -1.01 | 1.25 | 1.49 | 1.58 |
| arginase activity | 2 | 1.73 | -1.09 | 1.02 | -1.05 | -1.18 | 2.27 | 1.17 |
| arginine biosynthetic process | 2 | -22.15 | 1.64 | -12.84 | 1.4 | 1.07 | -7.77 | -1.97 |
| arginine biosynthetic process via ornithine | 1 | -15.39 | 1.51 | -7.96 | 1.39 | 1.15 | -4.77 | -1.11 |
| arginine catabolic process | 2 | -3.2 | -1.06 | -5.13 | -1.12 | -1.07 | -1.58 | 1.05 |
| arginine catabolic process to glutamate | 1 | -13.01 | 1.26 | -21.51 | 1.04 | 1.21 | -8.69 | 1.74 |
| arginine catabolic process to ornithine | 1 | 1.27 | -1.42 | -1.22 | -1.31 | -1.39 | 3.47 | -1.56 |
| arginine kinase activity | 3 | 1.01 | 1.07 | 1.29 | 1.05 | -1.11 | 1.23 | -1.22 |
| arginine metabolic process | 5 | -5.16 | 1.27 | -5.44 | 1.2 | 1.07 | -3.1 | -1.21 |
| arginine N-methyltransferase activity | 9 | 1.19 | 1.07 | 1.15 | 1.17 | 1.1 | 1.02 | 1.01 |
| arginine-tRNA ligase activity | 3 | 1.35 | 1.15 | 1.32 | 1.15 | 1.24 | 1.15 | 1.05 |
| argininosuccinate lyase activity | 1 | -15.39 | 1.51 | -7.96 | 1.39 | 1.15 | -4.77 | -1.11 |
| argininosuccinate metabolic process | 1 | -31.89 | 1.77 | -20.72 | 1.41 | 1.0 | -12.66 | -3.5 |
| argininosuccinate synthase activity | 1 | -31.89 | 1.77 | -20.72 | 1.41 | 1.0 | -12.66 | -3.5 |
| arginyl-tRNA aminoacylation | 3 | 1.35 | 1.15 | 1.32 | 1.15 | 1.24 | 1.15 | 1.05 |
| arginyltransferase activity | 1 | 1.03 | 1.39 | 1.46 | 1.24 | 1.37 | 1.69 | 1.36 |
| aromatic amino acid family catabolic process | 6 | 1.4 | -1.16 | -1.06 | -1.08 | -1.08 | 1.95 | -1.14 |
| aromatic amino acid family metabolic process | 19 | 1.42 | -1.17 | -1.18 | -1.07 | -1.13 | 1.48 | 1.04 |
| aromatic amino acid transmembrane transporter activity | 2 | 3.0 | -1.1 | 1.15 | -1.28 | -1.42 | 2.49 | 1.13 |
| aromatic compound biosynthetic process | 24 | 1.66 | -1.07 | -1.13 | -1.07 | -1.14 | 1.23 | 1.24 |
| aromatic compound catabolic process | 8 | -1.06 | -1.01 | -1.07 | -1.04 | -1.14 | 1.17 | -1.07 |
| aromatic-L-amino-acid decarboxylase activity | 4 | 2.04 | -1.66 | -1.74 | -1.59 | -1.59 | 1.51 | 1.84 |
| Arp2/3 complex-mediated actin nucleation | 2 | -1.4 | 1.24 | 1.37 | 1.14 | 1.19 | -1.91 | 1.02 |
| Arp2/3 protein complex | 5 | -3.04 | -1.69 | -1.35 | 1.45 | 1.29 | -2.9 | -1.36 |
| arsenite secondary active transmembrane transporter activity | 1 | 1.35 | 1.29 | 1.36 | 1.08 | 1.19 | 1.34 | 1.11 |
| arsenite transmembrane transporter activity | 2 | 2.24 | 1.06 | 1.22 | -1.13 | -1.15 | 2.07 | 1.19 |
| arsenite-transmembrane transporting ATPase activity | 1 | 1.35 | 1.29 | 1.36 | 1.08 | 1.19 | 1.34 | 1.11 |
| aryl hydrocarbon receptor binding | 1 | 1.71 | 1.13 | 1.25 | 1.13 | 1.02 | 1.11 | -1.02 |
| aryl sulfotransferase activity | 1 | 1.25 | -1.11 | -1.17 | -1.08 | -1.01 | 1.11 | 1.01 |
| arylamine N-acetyltransferase activity | 1 | -8.98 | 1.77 | -2.05 | -1.02 | -2.08 | -14.22 | 1.22 |
| aryldialkylphosphatase activity | 1 | 1.9 | -1.44 | -1.39 | -2.02 | 1.17 | 21.38 | -1.25 |
| asioloorosomucoid beta-1,3-glucuronosyltransferase activity | 2 | -1.0 | -1.2 | -1.45 | -1.61 | -1.38 | 1.39 | 5.09 |
| asparaginase activity | 4 | 1.31 | -1.05 | -1.24 | -1.15 | 1.04 | 1.97 | 1.03 |
| asparagine biosynthetic process | 2 | -1.07 | 1.2 | 1.14 | 1.26 | 1.17 | 1.27 | -1.14 |
| asparagine metabolic process | 2 | -1.07 | 1.2 | 1.14 | 1.26 | 1.17 | 1.27 | -1.14 |
| asparagine synthase (glutamine-hydrolyzing) activity | 2 | -1.07 | 1.2 | 1.14 | 1.26 | 1.17 | 1.27 | -1.14 |
| asparagine-tRNA ligase activity | 2 | -1.04 | 1.15 | 1.12 | 1.09 | 1.19 | -1.05 | 1.03 |
| asparaginyl-tRNA aminoacylation | 2 | -1.04 | 1.15 | 1.12 | 1.09 | 1.19 | -1.05 | 1.03 |
| aspartate 1-decarboxylase activity | 1 | 1.44 | -1.11 | -1.15 | 1.16 | -1.17 | -1.1 | -1.2 |
| aspartate carbamoyltransferase activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
| aspartate family amino acid biosynthetic process | 4 | 1.12 | 1.16 | -1.0 | 1.25 | 1.08 | 1.34 | -1.11 |
| aspartate family amino acid catabolic process | 2 | -1.01 | -1.12 | -1.04 | 1.37 | -1.27 | 1.52 | -1.61 |
| aspartate family amino acid metabolic process | 11 | 1.2 | -1.0 | -1.12 | 1.08 | -1.05 | 1.59 | -1.22 |
| aspartate metabolic process | 2 | 1.83 | 1.18 | -1.32 | -1.0 | 1.19 | 1.57 | 1.14 |
| aspartate oxidase activity | 2 | -2.82 | -1.69 | -2.22 | 1.7 | 1.95 | -1.63 | -1.83 |
| aspartate transport | 1 | 2.24 | 1.81 | -38.59 | -31.15 | -18.58 | -3.21 | 4.55 |
| aspartate-tRNA ligase activity | 1 | -1.97 | 1.61 | 1.28 | -1.18 | 1.45 | -1.88 | 1.38 |
| aspartic endopeptidase activity, intramembrane cleaving | 2 | -1.09 | 1.35 | -1.07 | 1.16 | -1.03 | -1.2 | 1.46 |
| aspartic-type endopeptidase activity | 19 | -1.6 | -1.03 | 1.15 | -1.16 | -1.46 | -1.86 | -1.32 |
| aspartic-type peptidase activity | 19 | -1.6 | -1.03 | 1.15 | -1.16 | -1.46 | -1.86 | -1.32 |
| aspartyl-tRNA aminoacylation | 1 | -1.97 | 1.61 | 1.28 | -1.18 | 1.45 | -1.88 | 1.38 |
| assembly of actomyosin apparatus involved in cell cycle cytokinesis | 14 | 1.26 | -1.24 | -1.03 | -1.27 | 1.08 | 1.13 | 1.08 |
| associative learning | 55 | 1.1 | 1.08 | 1.18 | 1.01 | 1.2 | 1.31 | 1.21 |
| aster | 7 | -1.26 | 1.17 | 1.31 | 1.12 | 1.35 | -1.04 | 1.04 |
| astral microtubule | 4 | -1.02 | 1.17 | 1.36 | -1.01 | 1.32 | 1.27 | 1.24 |
| astral microtubule organization | 2 | 1.07 | 1.11 | 1.15 | 1.21 | 1.27 | 1.05 | 1.05 |
| asymmetric cell division | 66 | 1.06 | 1.13 | 1.27 | 1.08 | 1.35 | 1.05 | 1.13 |
| asymmetric neuroblast division | 29 | -1.27 | 1.18 | 1.38 | 1.18 | 1.43 | -1.04 | 1.05 |
| asymmetric neuroblast division resulting in ganglion mother cell formation | 2 | -1.54 | 1.67 | 1.31 | 1.18 | 1.85 | -1.54 | 1.65 |
| asymmetric protein localization | 36 | -1.02 | 1.11 | 1.3 | 1.09 | 1.44 | 1.21 | 1.16 |
| asymmetric protein localization involved in cell fate determination | 14 | -1.35 | 1.16 | 1.3 | 1.08 | 1.48 | 1.01 | 1.07 |
| AT DNA binding | 5 | 1.49 | -1.14 | -1.13 | 1.14 | 1.47 | 1.04 | 1.12 |
| ATP binding | 652 | 1.06 | 1.1 | 1.17 | 1.09 | 1.22 | 1.18 | 1.09 |
| ATP biosynthetic process | 25 | 1.34 | 1.04 | 1.24 | -1.05 | 1.09 | 1.66 | -1.1 |
| ATP catabolic process | 2 | 1.12 | 1.21 | 1.11 | 1.15 | 1.2 | 1.05 | 1.15 |
| ATP citrate synthase activity | 4 | -1.02 | -1.02 | -1.04 | -1.09 | -1.21 | 1.05 | -1.32 |
| ATP hydrolysis coupled proton transport | 32 | -1.37 | -1.01 | 1.29 | -1.18 | -1.14 | 1.31 | -1.13 |
| ATP metabolic process | 36 | 1.35 | -1.02 | 1.24 | -1.12 | 1.07 | 1.65 | -1.08 |
| ATP synthesis coupled electron transport | 59 | 1.05 | 1.03 | 1.22 | 1.05 | 1.09 | 1.56 | -1.33 |
| ATP synthesis coupled proton transport | 18 | 1.37 | -1.0 | 1.2 | -1.02 | 1.12 | 1.7 | -1.2 |
| ATP transport | 2 | -1.19 | 1.19 | 1.41 | 1.1 | 1.28 | 1.45 | -1.24 |
| ATP-activated inward rectifier potassium channel activity | 1 | -2.21 | 1.6 | 1.01 | 1.47 | -3.02 | -10.91 | -2.13 |
| ATP-binding cassette (ABC) transporter complex | 41 | 1.23 | -1.2 | -1.24 | -1.08 | 1.0 | 1.04 | -1.04 |
| ATP-dependent 3'-5' DNA helicase activity | 2 | -1.1 | 1.25 | 1.24 | 1.2 | 1.14 | 1.04 | 1.15 |
| ATP-dependent chromatin remodeling | 11 | 1.15 | 1.19 | 1.36 | 1.14 | 1.3 | 1.34 | 1.2 |
| ATP-dependent DNA helicase activity | 19 | 1.12 | 1.17 | 1.33 | 1.14 | 1.3 | 1.15 | 1.17 |
| ATP-dependent helicase activity | 76 | 1.18 | 1.21 | 1.34 | 1.17 | 1.3 | 1.31 | 1.19 |
| ATP-dependent peptidase activity | 3 | -1.2 | 1.29 | 1.23 | 1.11 | 1.07 | 1.26 | 1.04 |
| ATP-dependent RNA helicase activity | 38 | 1.22 | 1.21 | 1.3 | 1.2 | 1.31 | 1.37 | 1.16 |
| ATP-sensitive potassium channel complex | 1 | 2.13 | 1.07 | 1.24 | -1.07 | 1.02 | 1.64 | 1.13 |
| ATP:ADP antiporter activity | 2 | -1.19 | 1.19 | 1.41 | 1.1 | 1.28 | 1.45 | -1.24 |
| ATPase activator activity | 3 | 1.77 | 1.07 | 1.2 | 1.24 | 1.37 | 1.32 | 1.35 |
| ATPase activity | 318 | -1.02 | 1.05 | 1.15 | 1.04 | 1.13 | 1.15 | 1.03 |
| ATPase activity, coupled | 283 | -1.01 | 1.06 | 1.16 | 1.03 | 1.13 | 1.15 | 1.04 |
| ATPase activity, coupled to movement of substances | 120 | -1.08 | -1.04 | 1.03 | -1.07 | 1.02 | 1.16 | -1.05 |
| ATPase activity, coupled to transmembrane movement of ions | 67 | -1.16 | 1.01 | 1.26 | -1.1 | -1.0 | 1.35 | -1.07 |
| ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism | 61 | -1.2 | 1.0 | 1.27 | -1.12 | -1.01 | 1.39 | -1.09 |
| ATPase activity, coupled to transmembrane movement of substances | 120 | -1.08 | -1.04 | 1.03 | -1.07 | 1.02 | 1.16 | -1.05 |
| ATPase regulator activity | 4 | 1.49 | 1.1 | 1.13 | 1.22 | 1.27 | 1.15 | 1.16 |
| attachment of GPI anchor to protein | 2 | 1.49 | 1.08 | 1.21 | 1.27 | 1.12 | -1.05 | -1.02 |
| attachment of spindle microtubules to chromosome | 5 | -1.0 | 1.08 | 1.05 | 1.15 | 1.21 | 1.0 | 1.02 |
| attachment of spindle microtubules to kinetochore | 4 | -1.03 | 1.09 | 1.07 | 1.08 | 1.18 | 1.05 | 1.05 |
| attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation | 1 | -1.24 | -1.06 | -1.4 | -1.21 | -1.33 | -1.23 | -1.12 |
| attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation | 1 | -1.05 | 1.32 | 1.38 | -1.11 | 1.3 | 2.36 | 1.79 |
| AU-rich element binding | 1 | -1.76 | 1.11 | 1.26 | 1.23 | 1.05 | -1.22 | -1.69 |
| auditory behavior | 1 | -1.09 | 1.11 | 1.03 | 1.13 | -1.08 | 1.11 | -1.0 |
| autophagic cell death | 70 | 1.04 | -1.0 | 1.1 | 1.06 | 1.23 | 1.21 | 1.11 |
| autophagic vacuole assembly | 2 | 1.21 | 1.14 | -1.0 | 1.38 | 1.03 | -1.03 | -1.25 |
| autophagic vacuole fusion | 2 | 1.14 | 1.16 | 1.85 | 1.13 | 1.26 | 1.5 | 1.09 |
| autophagy | 25 | 1.13 | 1.2 | 1.42 | 1.16 | 1.34 | 1.29 | 1.18 |
| autosome | 1 | 1.07 | 1.1 | 1.33 | 1.13 | 1.37 | -1.12 | 1.05 |
| axis specification | 164 | 1.24 | 1.06 | 1.24 | 1.03 | 1.22 | 1.3 | 1.23 |
| axolemma | 1 | -1.08 | -1.3 | -1.04 | 1.04 | 1.56 | 8.15 | 2.89 |
| axon | 64 | 1.18 | 1.07 | 1.23 | -1.05 | 1.23 | 1.51 | 1.31 |
| axon cargo transport | 16 | 1.1 | 1.21 | 1.27 | 1.13 | 1.19 | 1.36 | 1.14 |
| axon choice point recognition | 24 | 1.17 | 1.11 | 1.3 | 1.03 | 1.22 | 1.12 | 1.17 |
| axon ensheathment | 6 | 1.77 | -1.07 | 1.38 | -1.13 | 1.24 | 3.0 | 1.46 |
| axon extension | 21 | 1.21 | 1.14 | 1.27 | 1.01 | 1.26 | 1.1 | 1.2 |
| axon extension involved in axon guidance | 2 | -1.19 | -1.04 | -1.25 | -1.1 | -1.33 | -1.25 | -1.21 |
| axon extension involved in development | 6 | 1.15 | 1.12 | 1.61 | 1.08 | 1.39 | 1.07 | 1.23 |
| axon guidance | 181 | 1.1 | 1.08 | 1.23 | 1.01 | 1.27 | 1.29 | 1.31 |
| axon guidance receptor activity | 4 | -1.18 | -1.02 | 1.16 | -1.02 | 1.15 | -1.24 | 1.14 |
| axon midline choice point recognition | 19 | 1.15 | 1.12 | 1.41 | 1.02 | 1.3 | 1.17 | 1.22 |
| axon part | 31 | 1.25 | 1.05 | 1.11 | -1.11 | 1.16 | 1.72 | 1.28 |
| axon regeneration | 3 | -1.12 | 1.14 | 1.65 | 1.16 | 1.31 | -1.01 | 1.22 |
| axon target recognition | 15 | -1.0 | 1.14 | 1.31 | 1.09 | 1.01 | -1.17 | 1.08 |
| axon terminus | 26 | 1.26 | 1.07 | 1.08 | -1.15 | 1.13 | 1.67 | 1.27 |
| axon transport of mitochondrion | 3 | 1.06 | 1.09 | 1.22 | 1.23 | 1.2 | 1.22 | -1.08 |
| axonal defasciculation | 11 | -1.03 | -1.0 | 1.06 | -1.05 | 1.13 | 1.11 | 1.26 |
| axonal fasciculation | 14 | -1.38 | -1.31 | -1.09 | -1.08 | 1.2 | 1.11 | -1.02 |
| axonal growth cone | 3 | 1.35 | 1.17 | 1.49 | 1.21 | 1.37 | 1.33 | 1.2 |
| axonemal dynein complex | 12 | -1.02 | 1.03 | 1.04 | 1.02 | -1.05 | 1.0 | -1.11 |
| axonemal microtubule | 1 | -1.31 | -1.04 | -1.2 | -1.01 | -1.13 | -1.03 | -1.15 |
| axoneme | 14 | -1.03 | 1.04 | 1.03 | 1.02 | -1.05 | -1.01 | -1.1 |
| axoneme assembly | 9 | -1.07 | 1.1 | 1.21 | 1.07 | 1.11 | -1.04 | -1.0 |
| axoneme part | 13 | -1.04 | 1.02 | 1.03 | 1.02 | -1.05 | 1.0 | -1.11 |
| axonogenesis | 233 | 1.11 | 1.08 | 1.25 | 1.0 | 1.27 | 1.27 | 1.31 |
| axonogenesis involved in innervation | 1 | -2.0 | 1.87 | 1.43 | 1.14 | 2.42 | -2.25 | 1.78 |
| B cell mediated immunity | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
| bacterial cell surface binding | 13 | 1.62 | -1.3 | -1.27 | -1.27 | -1.21 | 1.78 | -1.04 |
| bacterial-type flagellum | 1 | -1.07 | -1.0 | -1.08 | -1.04 | -1.09 | -1.14 | 1.31 |
| barbed-end actin filament capping | 2 | -1.38 | -1.03 | 2.18 | 1.01 | 1.59 | -1.39 | -1.04 |
| basal cortex | 7 | -1.21 | 1.31 | 1.34 | 1.19 | 1.4 | -1.05 | 1.17 |
| basal lamina | 3 | 2.42 | -1.01 | 1.11 | -1.14 | 1.47 | 4.1 | 1.43 |
| basal part of cell | 11 | -1.08 | 1.22 | 1.48 | 1.16 | 1.48 | 1.32 | 1.21 |
| basal plasma membrane | 1 | 1.33 | 1.32 | 2.26 | 1.11 | 1.52 | 1.39 | 1.48 |
| basal protein localization | 6 | -1.45 | 1.22 | 1.54 | 1.08 | 1.45 | -1.08 | -1.07 |
| basal RNA polymerase II transcription machinery binding | 8 | 1.09 | 1.07 | 1.15 | 1.14 | 1.23 | 1.02 | 1.08 |
| basal transcription machinery binding | 8 | 1.09 | 1.07 | 1.15 | 1.14 | 1.23 | 1.02 | 1.08 |
| base conversion or substitution editing | 1 | 1.13 | 1.14 | 1.55 | 1.01 | 1.4 | 2.0 | 1.26 |
| base pairing | 2 | 1.38 | 1.09 | 1.14 | 1.35 | 1.29 | -1.02 | -1.04 |
| base pairing with RNA | 2 | 1.38 | 1.09 | 1.14 | 1.35 | 1.29 | -1.02 | -1.04 |
| base pairing with rRNA | 2 | 1.38 | 1.09 | 1.14 | 1.35 | 1.29 | -1.02 | -1.04 |
| base-excision repair | 6 | 1.51 | -1.01 | 1.25 | 1.11 | 1.19 | 1.33 | -1.13 |
| base-excision repair, AP site formation | 1 | 1.23 | 1.13 | 1.14 | 1.14 | 1.15 | 1.01 | 1.07 |
| basement membrane | 10 | 1.55 | -1.19 | 1.13 | -1.32 | 1.1 | 2.13 | 1.42 |
| basement membrane assembly | 1 | -1.47 | 1.17 | 2.02 | 1.22 | 1.63 | -1.12 | 1.4 |
| basement membrane disassembly | 3 | -2.47 | 1.3 | 1.22 | 1.11 | 1.41 | -1.09 | 1.18 |
| basement membrane organization | 5 | -1.2 | 1.03 | 1.32 | -1.01 | 1.32 | 1.16 | 1.46 |
| basolateral plasma membrane | 34 | 1.42 | 1.0 | 1.32 | -1.08 | 1.36 | 1.58 | 1.36 |
| behavior | 399 | 1.11 | -1.01 | 1.12 | -1.04 | 1.1 | 1.22 | 1.16 |
| behavioral interaction between organisms | 120 | 1.07 | -1.05 | 1.06 | -1.03 | 1.01 | 1.21 | 1.15 |
| behavioral response to cocaine | 9 | 1.31 | 1.15 | 1.55 | 1.04 | 1.35 | 1.53 | 1.26 |
| behavioral response to ethanol | 35 | 1.52 | -1.02 | 1.16 | -1.06 | 1.28 | 1.26 | 1.37 |
| behavioral response to ether | 2 | -1.03 | 1.05 | -1.07 | -1.06 | -1.12 | 1.18 | -1.13 |
| behavioral response to nicotine | 1 | 1.09 | 1.23 | 3.2 | 1.05 | 2.53 | 1.91 | 1.95 |
| behavioral response to nutrient | 5 | -1.0 | -1.02 | 1.2 | 1.04 | 1.13 | 1.24 | 1.12 |
| behavioral response to pain | 2 | 1.88 | -1.18 | 1.22 | 1.16 | 1.43 | 1.98 | 1.19 |
| behavioral response to starvation | 4 | -1.14 | -2.62 | -2.82 | -2.72 | -3.01 | -3.18 | 1.82 |
| bent DNA binding | 2 | 1.7 | 1.14 | 1.37 | 1.1 | 1.36 | 1.18 | 1.22 |
| benzene-containing compound metabolic process | 9 | -1.02 | -1.18 | -1.26 | -1.16 | -1.28 | -1.1 | 1.52 |
| benzodiazepine receptor activity | 1 | -1.12 | -1.26 | 1.76 | 1.06 | 1.23 | -1.31 | -1.61 |
| beta-1,3-galactosyltransferase activity | 10 | 1.35 | 1.03 | 1.08 | 1.01 | -1.01 | 1.23 | 1.16 |
| beta-1,4-mannosylglycolipid beta-1,3-N-acetylglucosaminyltransferase activity | 1 | 1.3 | 1.32 | 1.55 | 1.56 | 1.38 | -1.43 | -1.27 |
| beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | 1 | 3.39 | -1.12 | 1.06 | -1.11 | 1.06 | 1.27 | -1.12 |
| beta-1,4-mannosyltransferase activity | 2 | -2.16 | 1.25 | 1.27 | 1.12 | 1.95 | -1.56 | -1.08 |
| beta-alanine biosynthetic process | 1 | 1.44 | -1.11 | -1.15 | 1.16 | -1.17 | -1.1 | -1.2 |
| beta-alanine metabolic process | 1 | 1.44 | -1.11 | -1.15 | 1.16 | -1.17 | -1.1 | -1.2 |
| beta-alanyl-dopamine hydrolase activity | 1 | -1.31 | -1.76 | 1.72 | 1.22 | 1.97 | 3.11 | 1.28 |
| beta-alanyl-dopamine synthase activity | 1 | 1.36 | 1.09 | 1.02 | -1.03 | -1.16 | 1.04 | 1.01 |
| beta-alanyl-histamine hydrolase activity | 1 | -1.31 | -1.76 | 1.72 | 1.22 | 1.97 | 3.11 | 1.28 |
| beta-amyloid binding | 1 | -1.11 | 1.12 | -1.05 | 1.06 | -1.09 | -1.06 | -1.01 |
| beta-carotene 15,15'-monooxygenase activity | 1 | 1.12 | -1.01 | 1.14 | 1.06 | 1.09 | 1.14 | -1.06 |
| beta-catenin binding | 9 | 1.09 | 1.18 | 1.31 | 1.15 | 1.46 | 1.17 | 1.28 |
| beta-galactosidase activity | 2 | -4.22 | 1.94 | -2.65 | -1.31 | -2.65 | -1.75 | -2.68 |
| beta-galactoside alpha-2,6-sialyltransferase activity | 1 | 1.19 | 1.12 | 1.07 | 1.08 | 1.03 | 1.22 | -1.05 |
| beta-glucosidase activity | 1 | -1.02 | 1.14 | 1.14 | 1.39 | 1.15 | 1.04 | -1.06 |
| beta-glucuronidase activity | 2 | -2.98 | 1.22 | 1.8 | 1.28 | 1.95 | -1.65 | 1.15 |
| beta-heterochromatin | 1 | 1.4 | 1.27 | 1.49 | -1.01 | 1.2 | 1.7 | 1.58 |
| beta-lactam antibiotic biosynthetic process | 1 | -1.31 | -1.76 | 1.72 | 1.22 | 1.97 | 3.11 | 1.28 |
| beta-lactam antibiotic metabolic process | 1 | -1.31 | -1.76 | 1.72 | 1.22 | 1.97 | 3.11 | 1.28 |
| beta-mannosidase activity | 1 | -5.95 | 1.18 | 1.25 | 1.37 | 1.4 | -3.3 | -1.02 |
| beta-N-acetylgalactosaminidase activity | 1 | 3.13 | 1.28 | 1.73 | 1.05 | 1.33 | 2.12 | 2.37 |
| beta-N-acetylglucosaminidase activity | 3 | 3.05 | -1.03 | -1.72 | -1.02 | 1.13 | -1.04 | 1.42 |
| beta-N-acetylhexosaminidase activity | 4 | 2.6 | -1.04 | -1.38 | 1.02 | 1.14 | -1.03 | 1.23 |
| beta-ureidopropionase activity | 1 | 17.28 | -3.07 | -1.83 | -2.92 | -2.4 | 3.32 | 1.6 |
| betaine biosynthetic process | 1 | 1.3 | -1.08 | -1.07 | -1.13 | -1.19 | 1.96 | -1.06 |
| betaine metabolic process | 2 | -1.01 | -1.08 | -1.06 | -1.12 | -1.16 | 1.15 | -1.15 |
| betaine transport | 2 | 1.34 | 1.32 | -1.91 | 1.22 | 1.14 | -1.7 | -1.23 |
| bHLH transcription factor binding | 1 | 1.46 | 1.06 | -1.06 | 1.12 | -1.04 | -1.02 | 1.13 |
| bicarbonate transmembrane transporter activity | 1 | 1.2 | -1.03 | 1.07 | -1.04 | 1.13 | 1.1 | 1.23 |
| bicarbonate transport | 1 | 1.2 | -1.03 | 1.07 | -1.04 | 1.13 | 1.1 | 1.23 |
| bicoid mRNA localization | 8 | 1.29 | 1.08 | 1.35 | 1.13 | 1.31 | 1.35 | 1.11 |
| bidentate ribonuclease III activity | 1 | -1.14 | 1.08 | 1.42 | -1.27 | 1.25 | 1.05 | 1.3 |
| bile acid metabolic process | 1 | -1.02 | 1.14 | 1.14 | 1.39 | 1.15 | 1.04 | -1.06 |
| bile acid transmembrane transporter activity | 2 | -3.13 | 1.41 | -2.05 | 1.29 | -3.5 | -4.18 | -1.28 |
| bile acid:sodium symporter activity | 2 | -3.13 | 1.41 | -2.05 | 1.29 | -3.5 | -4.18 | -1.28 |
| biliverdin reductase activity | 1 | -1.51 | 1.45 | 1.08 | 1.06 | -1.12 | -1.58 | -1.42 |
| binding | 4696 | 1.06 | 1.02 | 1.07 | 1.04 | 1.11 | 1.08 | 1.06 |
| binding, bridging | 17 | -1.01 | 1.02 | 1.14 | 1.03 | 1.09 | 1.16 | 1.1 |
| biological adhesion | 172 | 1.2 | -1.06 | 1.06 | -1.06 | 1.19 | 1.34 | 1.23 |
| biological regulation | 2649 | 1.15 | 1.05 | 1.17 | 1.04 | 1.17 | 1.17 | 1.12 |
| biological_process | 8429 | 1.02 | -1.01 | 1.01 | 1.01 | 1.06 | 1.03 | 1.0 |
| biosynthetic process | 1003 | 1.19 | 1.05 | 1.09 | 1.06 | 1.14 | 1.18 | 1.04 |
| biotin carboxylase activity | 3 | 2.88 | 1.25 | -1.21 | -1.16 | -1.0 | 2.26 | 1.91 |
| biotin-[acetyl-CoA-carboxylase] ligase activity | 1 | 1.43 | 1.46 | 1.44 | 1.24 | 1.28 | 1.18 | 1.38 |
| biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity | 1 | 1.43 | 1.46 | 1.44 | 1.24 | 1.28 | 1.18 | 1.38 |
| biotin-protein ligase activity | 1 | 1.43 | 1.46 | 1.44 | 1.24 | 1.28 | 1.18 | 1.38 |
| bis(5'-adenosyl)-triphosphatase activity | 1 | 2.29 | 1.26 | 1.38 | 1.23 | 1.51 | 1.35 | -1.03 |
| bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity | 1 | -1.85 | 1.12 | 1.37 | 1.12 | 1.23 | -1.02 | 1.02 |
| bis(5'-nucleosyl)-tetraphosphatase activity | 1 | -1.85 | 1.12 | 1.37 | 1.12 | 1.23 | -1.02 | 1.02 |
| bitter taste receptor activity | 2 | -1.31 | -1.2 | -1.22 | -1.24 | 3.17 | 1.22 | -1.17 |
| blastoderm segmentation | 173 | 1.2 | 1.1 | 1.26 | 1.04 | 1.23 | 1.26 | 1.24 |
| BLOC complex | 6 | 1.36 | 1.17 | 1.47 | 1.26 | 1.26 | 1.6 | -1.09 |
| BLOC-1 complex | 6 | 1.36 | 1.17 | 1.47 | 1.26 | 1.26 | 1.6 | -1.09 |
| blood circulation | 3 | -1.25 | 1.41 | -1.37 | -1.01 | 1.12 | 1.05 | 1.18 |
| blood coagulation | 1 | 1.05 | 1.37 | 1.17 | 1.34 | 1.05 | 1.15 | 1.1 |
| blue light photoreceptor activity | 1 | 1.37 | -1.11 | -1.04 | 1.15 | 1.03 | 2.71 | 1.13 |
| BMP signaling pathway | 11 | 1.35 | 1.07 | 1.35 | 1.04 | 1.18 | 1.02 | 1.19 |
| BMP signaling pathway involved in Malpighian tubule cell chemotaxis | 3 | 2.04 | 1.05 | 1.89 | -1.07 | 1.16 | 1.0 | 1.3 |
| BMP signaling pathway involved in spinal cord dorsal/ventral patterning | 1 | 6.63 | -1.06 | 1.58 | -1.04 | 1.02 | 3.09 | 1.27 |
| body fluid secretion | 5 | -1.82 | -1.14 | 1.09 | 1.02 | 1.2 | -2.0 | -1.34 |
| body morphogenesis | 19 | -1.01 | -1.0 | -1.07 | -1.04 | -1.14 | -1.01 | -1.14 |
| Bolwig's organ development | 9 | 1.23 | -1.01 | 1.15 | 1.06 | 1.23 | 1.18 | 1.03 |
| Bolwig's organ morphogenesis | 9 | 1.23 | -1.01 | 1.15 | 1.06 | 1.23 | 1.18 | 1.03 |
| bombesin receptor activity | 2 | 1.03 | 1.12 | 1.37 | -1.03 | -1.15 | 1.42 | 1.13 |
| bombesin receptor signaling pathway | 2 | 1.03 | 1.12 | 1.37 | -1.03 | -1.15 | 1.42 | 1.13 |
| border follicle cell delamination | 3 | 1.2 | 1.5 | 1.32 | 1.16 | 1.13 | 2.96 | 1.24 |
| border follicle cell migration | 72 | 1.05 | 1.17 | 1.45 | 1.13 | 1.49 | 1.2 | 1.21 |
| boss receptor activity | 1 | 2.09 | -1.24 | -1.34 | -1.08 | -1.33 | -1.62 | 1.07 |
| box C/D snoRNA binding | 1 | 1.11 | -1.14 | 1.0 | 1.3 | 1.17 | -1.17 | -1.17 |
| box H/ACA RNP complex | 1 | 1.3 | 1.21 | 1.13 | 1.29 | 1.21 | 1.06 | 1.05 |
| box H/ACA snoRNP complex | 1 | 1.3 | 1.21 | 1.13 | 1.29 | 1.21 | 1.06 | 1.05 |
| brahma complex | 9 | 1.16 | 1.17 | 1.42 | 1.17 | 1.47 | 1.4 | 1.29 |
| brain development | 99 | 1.09 | 1.08 | 1.33 | 1.05 | 1.24 | 1.12 | 1.14 |
| brain morphogenesis | 15 | 1.06 | 1.14 | 1.38 | 1.07 | 1.42 | 1.16 | 1.21 |
| brain segmentation | 4 | -1.45 | -1.33 | 2.24 | -1.39 | -1.52 | -1.44 | -1.38 |
| branch fusion, open tracheal system | 19 | -1.07 | 1.1 | 1.35 | 1.01 | 1.36 | 1.22 | 1.46 |
| branched chain family amino acid biosynthetic process | 1 | 5.21 | 1.63 | 1.44 | -1.45 | -2.46 | 1.42 | 2.6 |
| branched chain family amino acid catabolic process | 2 | 1.3 | 1.33 | 1.23 | 1.08 | 1.06 | 1.1 | -1.0 |
| branched chain family amino acid metabolic process | 7 | 1.25 | 1.54 | 1.17 | 1.06 | -1.04 | 1.35 | 1.33 |
| branched duct epithelial cell fate determination, open tracheal system | 8 | 2.56 | -1.13 | -1.03 | -1.23 | 1.24 | 1.31 | 1.76 |
| branched-chain aliphatic amino acid transport | 3 | 1.2 | -1.03 | -1.17 | 1.06 | 1.15 | -1.13 | 2.49 |
| branched-chain-amino-acid transaminase activity | 1 | 5.21 | 1.63 | 1.44 | -1.45 | -2.46 | 1.42 | 2.6 |
| branching involved in open tracheal system development | 45 | 1.12 | 1.12 | 1.47 | 1.03 | 1.34 | 1.29 | 1.3 |
| branching morphogenesis of a tube | 45 | 1.12 | 1.12 | 1.47 | 1.03 | 1.34 | 1.29 | 1.3 |
| brush border | 3 | -22.7 | -1.04 | -2.81 | 1.01 | -1.94 | 1.91 | -2.7 |
| bursicon neuropeptide hormone complex | 2 | -1.74 | -1.0 | -1.2 | 1.19 | 1.42 | -1.55 | -1.19 |
| C-4 methylsterol oxidase activity | 2 | -1.31 | -6.89 | -7.44 | -1.07 | -3.2 | -1.65 | -1.68 |
| C-acetyltransferase activity | 3 | 1.18 | 1.04 | -1.11 | 1.03 | -1.14 | 1.32 | -1.35 |
| C-acyltransferase activity | 8 | 1.16 | 1.02 | 1.03 | 1.15 | 1.21 | -1.21 | -1.3 |
| C-methyltransferase activity | 2 | -1.09 | 1.1 | 1.25 | 1.35 | 1.18 | 1.22 | -1.29 |
| C-palmitoyltransferase activity | 2 | -2.24 | 1.07 | 2.48 | 1.17 | 1.31 | -1.71 | -1.18 |
| C-terminal protein amino acid modification | 2 | -1.4 | 1.08 | 1.03 | 1.29 | 1.32 | -1.28 | -1.35 |
| C-terminal protein methylation | 1 | -2.13 | 1.18 | 1.09 | 1.41 | 1.8 | -1.71 | -1.76 |
| C-terminal protein-tyrosinylation | 1 | 1.09 | -1.0 | -1.03 | 1.18 | -1.04 | 1.05 | -1.03 |
| C2H2 zinc finger domain binding | 1 | 1.47 | -1.07 | -1.23 | 1.4 | -1.01 | -1.35 | -1.31 |
| C4-dicarboxylate transmembrane transporter activity | 7 | 1.08 | -1.13 | 1.39 | -1.2 | 1.08 | 1.99 | -1.07 |
| C4-dicarboxylate transport | 5 | -1.06 | -1.22 | 1.26 | -1.12 | 1.12 | 2.23 | -1.26 |
| CAAX-protein geranylgeranyltransferase activity | 2 | -2.28 | 1.15 | 1.11 | 1.06 | 1.05 | -2.22 | 1.78 |
| cadherin binding | 2 | 1.22 | -1.01 | 1.46 | 1.06 | 1.25 | 1.4 | 1.02 |
| cadmium ion transmembrane transport | 1 | -1.37 | 1.35 | 1.68 | 1.28 | 1.12 | -1.35 | -1.15 |
| cadmium ion transmembrane transporter activity | 1 | -1.37 | 1.35 | 1.68 | 1.28 | 1.12 | -1.35 | -1.15 |
| cadmium ion transport | 1 | -1.37 | 1.35 | 1.68 | 1.28 | 1.12 | -1.35 | -1.15 |
| Cajal body | 5 | 1.06 | 1.13 | 1.3 | 1.24 | 1.31 | 1.06 | -1.03 |
| Cajal body organization | 1 | -1.52 | 1.47 | 1.59 | 1.32 | 1.75 | -1.53 | 1.07 |
| calcineurin complex | 5 | 1.63 | -1.01 | 1.24 | 1.04 | 1.14 | 1.3 | 1.06 |
| calcitonin receptor activity | 5 | 1.36 | -1.25 | 1.11 | -1.21 | 1.02 | -1.07 | 1.56 |
| calcium activated cation channel activity | 3 | -1.25 | -1.55 | 1.25 | 1.49 | -1.39 | -1.46 | -1.49 |
| calcium channel activity | 24 | 1.39 | -1.04 | 1.09 | -1.06 | 1.15 | 1.41 | 1.14 |
| calcium channel complex | 4 | 1.36 | -1.08 | -1.02 | 1.02 | -1.08 | 1.17 | -1.12 |
| calcium channel regulator activity | 2 | -1.03 | -1.06 | -1.05 | -1.01 | -1.02 | -1.08 | -1.24 |
| calcium ion binding | 192 | 1.36 | -1.02 | 1.1 | -1.05 | 1.09 | 1.28 | 1.2 |
| calcium ion homeostasis | 10 | 1.86 | -1.02 | 1.36 | -1.1 | -1.04 | 1.64 | 1.18 |
| calcium ion transmembrane transport | 7 | 1.59 | 1.03 | 1.19 | -1.08 | -1.01 | 1.55 | 1.32 |
| calcium ion transmembrane transporter activity | 11 | -1.32 | 1.18 | 1.08 | -1.02 | 1.12 | -1.09 | 1.13 |
| calcium ion transport | 24 | 1.54 | -1.04 | 1.07 | -1.11 | 1.19 | 1.63 | 1.19 |
| calcium ion transport into cytosol | 1 | 2.52 | 1.29 | 3.07 | -1.16 | 1.37 | 5.13 | 2.97 |
| calcium ion-dependent exocytosis of neurotransmitter | 1 | 1.37 | 1.07 | 1.15 | 1.12 | 1.04 | 1.3 | 1.03 |
| calcium sensitive guanylate cyclase activator activity | 1 | 4.81 | -1.03 | -1.02 | 1.21 | 1.81 | 1.05 | 1.23 |
| calcium, potassium:sodium antiporter activity | 5 | -1.42 | 1.17 | -1.18 | 1.1 | -1.14 | -1.59 | -1.02 |
| calcium- and calmodulin-dependent protein kinase complex | 2 | 1.81 | 1.24 | 1.48 | 1.18 | 1.44 | 2.31 | 1.51 |
| calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity | 1 | -1.09 | -1.0 | 1.07 | 1.3 | -1.04 | -1.15 | -1.07 |
| calcium- and calmodulin-responsive adenylate cyclase activity | 1 | 4.63 | 2.09 | 1.35 | -1.43 | -1.28 | 1.63 | 2.43 |
| calcium-activated potassium channel activity | 3 | -1.25 | -1.55 | 1.25 | 1.49 | -1.39 | -1.46 | -1.49 |
| calcium-dependent cell-cell adhesion | 18 | 1.55 | -1.07 | -1.04 | -1.12 | 1.13 | 1.76 | 1.45 |
| calcium-dependent cell-matrix adhesion | 2 | -3.06 | 1.2 | 1.48 | 1.02 | 1.55 | -3.22 | 1.1 |
| calcium-dependent cysteine-type endopeptidase activity | 4 | 2.12 | 1.16 | 1.44 | 1.14 | 1.21 | 1.24 | 1.16 |
| calcium-dependent phospholipase A2 activity | 1 | -1.04 | -1.03 | -1.01 | -1.13 | -1.15 | 1.09 | -1.0 |
| calcium-dependent phospholipid binding | 11 | 1.19 | -1.05 | 1.13 | 1.02 | 1.21 | 1.24 | 1.15 |
| calcium-dependent protein binding | 1 | -1.16 | -1.03 | -1.2 | -1.35 | 1.14 | -1.16 | 1.14 |
| calcium-dependent protein kinase activity | 3 | 1.12 | 1.04 | 2.13 | -1.07 | 1.01 | 3.21 | -1.04 |
| calcium-dependent protein kinase C activity | 3 | 1.12 | 1.04 | 2.13 | -1.07 | 1.01 | 3.21 | -1.04 |
| calcium-dependent protein serine/threonine kinase activity | 3 | 1.12 | 1.04 | 2.13 | -1.07 | 1.01 | 3.21 | -1.04 |
| calcium-dependent protein serine/threonine phosphatase activity | 6 | 1.52 | -1.02 | 1.2 | 1.05 | 1.13 | 1.24 | 1.06 |
| calcium-dependent protein serine/threonine phosphatase regulator activity | 4 | 1.2 | 1.0 | 1.18 | 1.05 | 1.13 | -1.01 | 1.02 |
| calcium-independent phospholipase A2 activity | 2 | 1.71 | 1.33 | 1.36 | 1.12 | 1.41 | 1.4 | 1.33 |
| calcium-induced calcium release activity | 1 | 2.63 | 1.01 | 1.53 | -1.05 | 1.46 | 2.52 | 1.76 |
| calcium-mediated signaling | 8 | -1.04 | 1.02 | -1.11 | 1.01 | -1.17 | 1.07 | -1.03 |
| calcium-release channel activity | 4 | 2.09 | 1.04 | 1.5 | 1.02 | 1.16 | 2.3 | 1.48 |
| calcium-transporting ATPase activity | 4 | -1.18 | -1.01 | 1.34 | -1.06 | 1.25 | -1.0 | 1.03 |
| calcium:cation antiporter activity | 7 | -1.41 | 1.31 | -1.04 | 1.01 | 1.05 | -1.14 | 1.2 |
| calcium:sodium antiporter activity | 2 | -1.37 | 1.7 | 1.3 | -1.23 | 1.65 | 2.01 | 1.96 |
| calmodulin binding | 30 | 1.18 | 1.09 | 1.27 | 1.05 | 1.23 | 1.34 | 1.23 |
| calmodulin-dependent cyclic-nucleotide phosphodiesterase activity | 1 | -1.09 | -1.0 | 1.07 | 1.3 | -1.04 | -1.15 | -1.07 |
| calmodulin-dependent protein kinase activity | 8 | 2.03 | 1.07 | 1.21 | 1.02 | 1.3 | 2.02 | 1.5 |
| camera-type eye development | 1 | -1.1 | -1.15 | -1.07 | -1.18 | 1.52 | 1.28 | 1.24 |
| cAMP biosynthetic process | 6 | 1.38 | -1.01 | 1.27 | 1.01 | 1.07 | 1.29 | 1.16 |
| cAMP metabolic process | 7 | 1.35 | 1.03 | 1.31 | -1.01 | 1.11 | 1.49 | 1.22 |
| cAMP response element binding protein binding | 1 | 2.75 | 1.33 | 1.9 | 1.11 | 2.22 | 3.34 | 2.0 |
| cAMP-dependent protein kinase activity | 3 | 1.72 | -1.04 | 1.4 | -1.32 | 1.33 | 4.14 | 1.26 |
| cAMP-dependent protein kinase complex | 6 | 1.3 | 1.06 | 1.3 | -1.12 | 1.18 | 1.98 | 1.03 |
| cAMP-dependent protein kinase regulator activity | 6 | -1.1 | 1.09 | 1.07 | 1.13 | 1.06 | -1.11 | -1.2 |
| cAMP-mediated signaling | 12 | 1.11 | 1.19 | 1.15 | -1.07 | 1.01 | 1.19 | 1.11 |
| canonical Wnt receptor signaling pathway | 8 | 1.24 | 1.0 | 1.39 | 1.04 | 1.59 | 1.21 | 1.49 |
| canonical Wnt receptor signaling pathway involved in heart development | 3 | 1.09 | 1.1 | 1.13 | 1.08 | 1.18 | 1.14 | 2.09 |
| carbamoyl phosphate biosynthetic process | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
| carbamoyl phosphate metabolic process | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
| carbamoyl-phosphate synthase (ammonia) activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
| carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
| carbohydrate binding | 166 | -1.92 | -1.36 | -1.53 | -1.23 | -1.33 | -1.85 | -1.01 |
| carbohydrate biosynthetic process | 54 | 1.37 | -1.06 | -1.04 | -1.09 | 1.09 | 1.31 | 1.23 |
| carbohydrate catabolic process | 70 | 1.14 | -1.3 | -1.52 | -1.28 | -1.28 | 1.14 | 1.27 |
| carbohydrate homeostasis | 5 | 1.14 | 1.16 | -1.21 | -1.59 | -1.34 | 1.07 | 1.69 |
| carbohydrate kinase activity | 14 | 1.04 | 1.03 | -1.21 | 1.04 | 1.14 | 1.34 | -1.15 |
| carbohydrate metabolic process | 349 | -1.3 | -1.19 | -1.48 | -1.16 | -1.22 | -1.28 | 1.04 |
| carbohydrate phosphatase activity | 5 | 3.03 | -1.36 | 1.1 | -1.47 | -1.11 | 2.72 | 1.19 |
| carbohydrate transmembrane transporter activity | 35 | -1.0 | -1.02 | -1.46 | -1.04 | -1.16 | -1.22 | 1.12 |
| carbohydrate transport | 13 | 1.22 | -1.13 | -1.12 | -1.07 | 1.01 | 1.59 | 1.23 |
| carbohydrate utilization | 1 | 1.08 | -1.16 | -1.09 | 1.12 | -1.12 | 1.04 | -1.07 |
| carbon monoxide binding | 1 | -1.13 | -1.1 | -1.21 | -1.08 | -1.27 | -1.0 | -1.19 |
| carbon utilization | 1 | 3.68 | 1.14 | -1.19 | 1.01 | 1.66 | 1.38 | 1.25 |
| carbon-carbon lyase activity | 32 | 1.06 | -1.12 | -1.24 | 1.0 | -1.0 | 1.08 | -1.03 |
| carbon-halide lyase activity | 1 | -1.05 | 1.06 | 1.25 | -1.2 | 1.21 | -1.46 | 1.19 |
| carbon-monoxide oxygenase activity | 1 | 2.72 | -3.32 | -2.57 | -3.03 | -1.93 | 22.15 | -2.83 |
| carbon-nitrogen ligase activity, with glutamine as amido-N-donor | 13 | 1.37 | 1.08 | -1.29 | -1.04 | -1.04 | 1.51 | 1.21 |
| carbon-nitrogen lyase activity | 5 | -2.25 | -1.05 | -1.88 | 1.19 | 2.05 | -1.63 | -1.2 |
| carbon-oxygen lyase activity | 52 | 1.11 | 1.04 | 1.1 | -1.06 | 1.02 | 1.15 | 1.05 |
| carbon-oxygen lyase activity, acting on phosphates | 1 | 2.12 | 1.31 | 1.32 | 1.23 | 1.73 | 1.01 | 2.0 |
| carbon-oxygen lyase activity, acting on polysaccharides | 1 | 1.35 | 1.02 | 1.15 | 1.05 | 1.09 | 1.1 | 1.03 |
| carbon-sulfur lyase activity | 6 | 1.18 | 1.18 | 1.05 | 1.05 | 1.02 | 1.08 | -1.01 |
| carbonate dehydratase activity | 17 | -1.34 | -1.07 | 1.2 | -1.25 | 1.01 | 1.12 | 1.01 |
| carbonyl reductase (NADPH) activity | 3 | 1.57 | 1.0 | -1.52 | -1.25 | -1.09 | 1.43 | 1.09 |
| carboxy-lyase activity | 25 | 1.06 | -1.19 | -1.28 | -1.05 | -1.03 | 1.05 | -1.03 |
| carboxy-terminal domain protein kinase complex | 9 | 1.46 | 1.1 | 1.45 | 1.27 | 1.49 | 1.36 | 1.12 |
| carboxyl- or carbamoyltransferase activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
| carboxyl-O-methyltransferase activity | 2 | 1.17 | 1.1 | 1.15 | 1.29 | 1.38 | 1.07 | -1.31 |
| carboxylesterase activity | 33 | -1.1 | 1.01 | -1.29 | -1.03 | -1.13 | -1.36 | -1.13 |
| carboxylic acid binding | 52 | -1.23 | -1.12 | -1.35 | 1.02 | 1.06 | -1.11 | -1.28 |
| carboxylic acid biosynthetic process | 65 | 1.05 | -1.1 | -1.35 | -1.11 | -1.17 | 1.1 | 1.09 |
| carboxylic acid catabolic process | 40 | 1.0 | -1.07 | -1.2 | -1.06 | 1.05 | 1.14 | -1.23 |
| carboxylic acid metabolic process | 239 | -1.01 | -1.01 | -1.15 | -1.03 | 1.0 | 1.06 | -1.05 |
| carboxylic acid transmembrane transporter activity | 86 | -1.42 | -1.03 | -1.43 | -1.14 | -1.01 | -1.05 | -1.13 |
| carboxylic acid transport | 54 | -1.28 | -1.1 | -1.53 | -1.18 | -1.03 | 1.07 | -1.12 |
| carboxylic ester hydrolase activity | 99 | -1.69 | -1.12 | -1.47 | -1.07 | -1.31 | -2.03 | -1.33 |
| carboxypeptidase activity | 35 | -2.91 | -1.85 | -1.55 | -1.01 | -1.63 | -3.14 | -1.86 |
| CARD domain binding | 1 | 1.78 | 1.11 | 1.56 | 1.24 | 1.76 | -1.03 | 1.11 |
| cardiac cell development | 1 | 1.07 | 1.18 | 1.43 | 1.07 | 1.41 | 1.26 | 1.4 |
| cardiac cell differentiation | 20 | 1.36 | -1.01 | 1.21 | -1.08 | 1.08 | 1.53 | 1.21 |
| cardiac cell fate commitment | 9 | 1.12 | 1.05 | 1.08 | 1.02 | 1.08 | 1.04 | 1.06 |
| cardiac cell fate determination | 4 | 1.32 | 1.0 | 1.08 | -1.04 | -1.05 | -1.0 | 1.04 |
| cardiac cell fate specification | 1 | -1.42 | 1.01 | 1.2 | 1.29 | 2.44 | -1.59 | 1.35 |
| cardiac muscle cell development | 1 | 1.07 | 1.18 | 1.43 | 1.07 | 1.41 | 1.26 | 1.4 |
| cardiac muscle cell differentiation | 2 | 1.04 | 1.06 | 1.29 | 1.05 | 1.22 | 1.1 | 1.23 |
| cardiac muscle contraction | 1 | -2.87 | 2.31 | -2.71 | -1.16 | 1.45 | 1.26 | 1.68 |
| cardiac muscle tissue development | 5 | 1.62 | -1.11 | 1.15 | -1.06 | 1.18 | 1.57 | 1.06 |
| cardioblast cell fate commitment | 6 | 1.11 | 1.0 | 1.08 | 1.01 | 1.1 | -1.11 | 1.03 |
| cardioblast cell fate determination | 4 | 1.32 | 1.0 | 1.08 | -1.04 | -1.05 | -1.0 | 1.04 |
| cardioblast cell fate specification | 1 | -1.42 | 1.01 | 1.2 | 1.29 | 2.44 | -1.59 | 1.35 |
| cardioblast differentiation | 12 | 1.8 | -1.05 | 1.29 | -1.1 | 1.12 | 1.16 | 1.3 |
| cardiolipin biosynthetic process | 1 | -3.36 | 1.4 | 1.32 | 1.25 | 1.35 | -2.25 | 1.21 |
| cardiolipin metabolic process | 1 | -3.36 | 1.4 | 1.32 | 1.25 | 1.35 | -2.25 | 1.21 |
| cardiolipin synthase activity | 1 | 1.31 | 1.29 | 1.34 | 1.27 | 1.36 | 1.03 | -1.44 |
| cardiovascular system development | 70 | 1.28 | -1.02 | 1.19 | -1.07 | 1.17 | 1.3 | 1.17 |
| cargo receptor activity | 36 | 1.1 | -1.14 | -1.08 | -1.02 | -1.03 | 1.05 | -1.08 |
| carnitine biosynthetic process | 1 | 1.3 | -1.08 | -1.07 | -1.13 | -1.19 | 1.96 | -1.06 |
| carnitine metabolic process | 2 | -1.01 | -1.08 | -1.06 | -1.12 | -1.16 | 1.15 | -1.15 |
| carnitine O-acetyltransferase activity | 3 | -1.35 | 1.07 | -1.21 | 1.11 | 1.17 | -1.19 | -1.2 |
| carnitine O-acyltransferase activity | 5 | 1.08 | 1.06 | -1.39 | 1.16 | 1.37 | -1.36 | -1.1 |
| carnitine O-octanoyltransferase activity | 1 | 2.33 | -1.31 | -2.71 | 1.32 | 2.24 | -2.61 | 1.02 |
| carnitine O-palmitoyltransferase activity | 1 | 1.55 | 1.41 | -1.09 | 1.13 | 1.34 | -1.06 | 1.05 |
| carnitine transport | 2 | 1.34 | 1.32 | -1.91 | 1.22 | 1.14 | -1.7 | -1.23 |
| carnitine transporter activity | 6 | -1.28 | 1.49 | -1.43 | -1.09 | -1.24 | -2.46 | -1.13 |
| carnitine:acyl carnitine antiporter activity | 2 | 1.34 | 1.32 | -1.91 | 1.22 | 1.14 | -1.7 | -1.23 |
| carotene metabolic process | 1 | 1.12 | -1.01 | 1.14 | 1.06 | 1.09 | 1.14 | -1.06 |
| carotenoid biosynthetic process | 1 | -1.0 | 1.21 | -1.05 | 1.12 | 1.06 | -1.02 | -1.03 |
| carotenoid dioxygenase activity | 1 | 1.12 | -1.01 | 1.14 | 1.06 | 1.09 | 1.14 | -1.06 |
| carotenoid metabolic process | 3 | -1.97 | -1.44 | -2.29 | 1.38 | 1.12 | -1.8 | -2.35 |
| carotenoid transport | 1 | -6.48 | -6.48 | -8.02 | 2.81 | 1.04 | -8.53 | -8.65 |
| caspase complex | 2 | -3.83 | 1.28 | 1.42 | 1.35 | 1.72 | -4.2 | -3.4 |
| catabolic process | 443 | 1.07 | -1.01 | -1.01 | 1.0 | 1.07 | 1.05 | 1.06 |
| catalase activity | 3 | 1.88 | -1.66 | -2.02 | -1.59 | -1.55 | 2.15 | -1.21 |
| catalytic activity | 3804 | -1.08 | -1.02 | -1.07 | 1.01 | 1.04 | -1.07 | -1.05 |
| catalytic step 2 spliceosome | 111 | 1.16 | 1.09 | 1.21 | 1.23 | 1.31 | 1.15 | -1.02 |
| catechol oxidase activity | 1 | 1.73 | 1.33 | 1.02 | 1.13 | -1.06 | -1.05 | 1.06 |
| catechol-containing compound biosynthetic process | 3 | -1.04 | -2.12 | -1.47 | -1.4 | -1.53 | 1.41 | 2.4 |
| catechol-containing compound catabolic process | 1 | -8.98 | 1.77 | -2.05 | -1.02 | -2.08 | -14.22 | 1.22 |
| catechol-containing compound metabolic process | 9 | -1.02 | -1.18 | -1.26 | -1.16 | -1.28 | -1.1 | 1.52 |
| catecholamine biosynthetic process | 3 | -1.04 | -2.12 | -1.47 | -1.4 | -1.53 | 1.41 | 2.4 |
| catecholamine catabolic process | 1 | -8.98 | 1.77 | -2.05 | -1.02 | -2.08 | -14.22 | 1.22 |
| catecholamine metabolic process | 9 | -1.02 | -1.18 | -1.26 | -1.16 | -1.28 | -1.1 | 1.52 |
| catecholamine transport | 2 | 3.07 | -1.44 | -1.47 | -1.28 | -1.45 | -1.2 | -1.42 |
| catenin complex | 2 | 1.43 | 1.06 | 1.57 | 1.11 | 1.6 | 1.7 | 1.6 |
| cation binding | 1428 | -1.0 | 1.0 | 1.0 | 1.02 | 1.08 | 1.03 | 1.02 |
| cation channel activity | 105 | 1.11 | -1.02 | 1.01 | -1.05 | -1.0 | 1.12 | -1.03 |
| cation channel complex | 25 | 1.07 | 1.02 | 1.08 | 1.02 | 1.04 | -1.01 | -1.04 |
| cation homeostasis | 36 | 1.04 | 1.04 | 1.42 | -1.04 | -1.04 | 1.32 | 1.1 |
| cation transmembrane transporter activity | 354 | -1.17 | -1.05 | -1.15 | -1.12 | -1.07 | 1.16 | -1.11 |
| cation transport | 213 | -1.06 | -1.03 | 1.05 | -1.06 | -1.02 | 1.21 | -1.05 |
| cation-transporting ATPase activity | 26 | 1.1 | 1.0 | 1.24 | -1.08 | 1.02 | 1.51 | -1.05 |
| cation:amino acid symporter activity | 13 | 1.13 | -1.27 | -2.32 | -1.57 | 1.11 | 1.18 | 1.23 |
| cation:cation antiporter activity | 11 | -1.7 | 1.18 | -1.14 | 1.01 | -1.19 | 1.42 | 1.03 |
| cation:chloride symporter activity | 4 | -2.12 | -1.32 | 1.67 | -1.4 | 1.05 | 1.49 | -1.53 |
| cation:sugar symporter activity | 8 | 1.06 | -1.15 | -1.17 | -1.12 | -1.18 | -1.05 | 1.82 |
| cationic amino acid transmembrane transporter activity | 5 | -2.27 | 1.25 | -1.58 | -1.02 | 1.06 | 1.04 | -1.06 |
| caveola | 1 | 3.68 | -1.06 | -1.03 | 1.16 | 1.0 | 1.99 | -1.04 |
| CCAAT-binding factor complex | 1 | 4.06 | 1.06 | 1.04 | 1.34 | 1.6 | 1.05 | 1.52 |
| CCR4-NOT complex | 7 | 1.25 | 1.15 | 1.58 | 1.15 | 1.35 | 1.67 | 1.21 |
| Cdc73/Paf1 complex | 2 | -1.06 | 1.05 | 1.02 | 1.24 | 1.1 | 1.21 | -1.3 |
| CDP-alcohol phosphatidyltransferase activity | 6 | -1.0 | 1.26 | 1.69 | 1.08 | 1.28 | -1.12 | 1.22 |
| CDP-alcohol phosphotransferase activity | 1 | -10.11 | 1.17 | -1.48 | 1.2 | 1.57 | -5.09 | -1.84 |
| CDP-diacylglycerol biosynthetic process | 1 | 3.07 | 1.1 | 2.07 | -1.42 | 3.13 | -1.11 | 1.4 |
| CDP-diacylglycerol metabolic process | 1 | 3.07 | 1.1 | 2.07 | -1.42 | 3.13 | -1.11 | 1.4 |
| CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity | 1 | 1.09 | 1.12 | -1.13 | 1.16 | 1.11 | -1.64 | -1.3 |
| CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity | 1 | 2.1 | -1.04 | 1.71 | -1.1 | 1.9 | -1.29 | 1.13 |
| CDP-diacylglycerol-serine O-phosphatidyltransferase activity | 1 | 1.61 | 1.37 | 2.22 | 1.0 | 1.13 | 1.67 | 1.83 |
| cell | 4600 | 1.14 | 1.06 | 1.13 | 1.06 | 1.16 | 1.15 | 1.06 |
| cell activation | 10 | 1.19 | 1.04 | 1.07 | 1.06 | -1.05 | 1.15 | 1.06 |
| cell adhesion | 161 | 1.22 | -1.06 | 1.07 | -1.06 | 1.21 | 1.38 | 1.25 |
| cell adhesion mediated by integrin | 2 | -1.31 | -1.12 | -1.25 | -1.23 | -1.34 | -1.41 | -1.27 |
| cell adhesion molecule binding | 17 | -1.29 | -1.01 | 1.2 | -1.06 | 1.34 | -1.06 | 1.2 |
| cell body | 27 | -1.0 | -1.02 | 1.19 | 1.05 | 1.12 | 1.07 | 1.01 |
| cell chemotaxis | 7 | 1.41 | -1.02 | 1.42 | 1.1 | 1.42 | -1.11 | -1.12 |
| cell chemotaxis involved in Malpighian tubule morphogenesis | 3 | 2.04 | 1.05 | 1.89 | -1.07 | 1.16 | 1.0 | 1.3 |
| cell communication | 1251 | 1.14 | 1.03 | 1.15 | 1.03 | 1.17 | 1.18 | 1.11 |
| cell competition in a multicellular organism | 8 | -1.44 | 1.26 | 1.72 | 1.12 | 1.65 | 1.02 | 1.13 |
| cell cortex | 86 | -1.07 | 1.18 | 1.41 | 1.09 | 1.4 | 1.22 | 1.2 |
| cell cortex part | 52 | -1.17 | 1.2 | 1.4 | 1.11 | 1.36 | 1.08 | 1.09 |
| cell cycle | 573 | 1.19 | 1.11 | 1.23 | 1.11 | 1.27 | 1.19 | 1.1 |
| cell cycle arrest | 8 | 1.45 | 1.2 | 1.34 | 1.1 | 1.36 | 1.5 | 1.38 |
| cell cycle checkpoint | 84 | 1.23 | 1.14 | 1.35 | 1.19 | 1.41 | 1.29 | 1.15 |
| cell cycle comprising mitosis without cytokinesis | 14 | 1.58 | -1.04 | 1.19 | -1.07 | 1.25 | 1.21 | 1.5 |
| cell cycle cytokinesis | 34 | 1.28 | 1.02 | 1.18 | -1.01 | 1.3 | 1.18 | 1.14 |
| cell cycle phase | 443 | 1.2 | 1.1 | 1.22 | 1.11 | 1.26 | 1.19 | 1.09 |
| cell cycle process | 518 | 1.19 | 1.1 | 1.22 | 1.11 | 1.27 | 1.19 | 1.09 |
| cell death | 153 | 1.07 | 1.04 | 1.16 | 1.06 | 1.25 | 1.12 | 1.14 |
| cell development | 815 | 1.17 | 1.08 | 1.24 | 1.04 | 1.25 | 1.26 | 1.2 |
| cell differentiation | 1609 | 1.15 | 1.07 | 1.19 | 1.06 | 1.21 | 1.19 | 1.12 |
| cell division | 175 | 1.03 | 1.09 | 1.25 | 1.09 | 1.33 | 1.06 | 1.09 |
| cell division site | 12 | -1.06 | 1.09 | 1.54 | 1.06 | 1.53 | 1.28 | 1.13 |
| cell division site part | 12 | -1.06 | 1.09 | 1.54 | 1.06 | 1.53 | 1.28 | 1.13 |
| cell elongation involved in imaginal disc-derived wing morphogenesis | 5 | 1.41 | 1.11 | 1.92 | 1.05 | 1.98 | 1.8 | 1.61 |
| cell envelope | 11 | 1.96 | -1.06 | 1.02 | -1.08 | -1.01 | 1.22 | 1.03 |
| cell fate commitment | 405 | 1.16 | 1.06 | 1.16 | 1.05 | 1.2 | 1.16 | 1.12 |
| cell fate commitment involved in formation of primary germ layers | 17 | 1.6 | 1.01 | 1.08 | -1.06 | 1.04 | 1.29 | 1.13 |
| cell fate determination | 122 | 1.2 | 1.07 | 1.23 | 1.02 | 1.24 | 1.19 | 1.2 |
| cell fate specification | 59 | 1.11 | 1.06 | 1.1 | 1.04 | 1.17 | -1.02 | 1.22 |
| cell fraction | 106 | -1.02 | -1.12 | -1.21 | -1.02 | 1.06 | -1.09 | -1.04 |
| cell growth | 59 | 1.22 | 1.13 | 1.38 | 1.04 | 1.43 | 1.35 | 1.28 |
| cell hair | 2 | 1.46 | 1.0 | 1.38 | -1.02 | 1.32 | 1.45 | 1.21 |
| cell junction | 105 | 1.39 | -1.0 | 1.25 | -1.05 | 1.25 | 1.62 | 1.33 |
| cell junction assembly | 37 | 1.87 | -1.1 | 1.3 | -1.15 | 1.23 | 2.13 | 1.42 |
| cell junction maintenance | 9 | -1.01 | 1.16 | 1.73 | 1.07 | 1.49 | 1.28 | 1.13 |
| cell junction organization | 46 | 1.6 | -1.06 | 1.34 | -1.1 | 1.25 | 1.87 | 1.32 |
| cell leading edge | 10 | 1.31 | 1.13 | 1.5 | 1.03 | 1.41 | 1.43 | 1.48 |
| cell maturation | 116 | 1.16 | 1.11 | 1.31 | 1.06 | 1.29 | 1.43 | 1.21 |
| cell migration | 188 | 1.14 | 1.09 | 1.33 | 1.05 | 1.37 | 1.23 | 1.22 |
| cell migration involved in gastrulation | 8 | 1.53 | -1.02 | 1.51 | -1.06 | 1.32 | 1.72 | 1.01 |
| cell morphogenesis | 428 | 1.11 | 1.09 | 1.24 | 1.04 | 1.25 | 1.24 | 1.24 |
| cell morphogenesis involved in differentiation | 351 | 1.14 | 1.09 | 1.26 | 1.04 | 1.28 | 1.28 | 1.26 |
| cell morphogenesis involved in Malpighian tubule morphogenesis | 1 | 3.86 | 1.45 | 2.61 | -1.03 | 2.28 | 4.0 | 3.57 |
| cell morphogenesis involved in neuron differentiation | 329 | 1.14 | 1.09 | 1.26 | 1.04 | 1.27 | 1.25 | 1.26 |
| cell motility | 198 | 1.13 | 1.09 | 1.32 | 1.04 | 1.35 | 1.22 | 1.2 |
| cell outer membrane | 2 | 2.45 | -1.01 | 1.06 | 1.01 | 1.14 | 1.16 | 1.19 |
| cell part | 4600 | 1.14 | 1.06 | 1.13 | 1.06 | 1.16 | 1.15 | 1.06 |
| cell part morphogenesis | 359 | 1.11 | 1.08 | 1.23 | 1.04 | 1.24 | 1.23 | 1.23 |
| cell periphery | 658 | 1.15 | 1.02 | 1.13 | -1.02 | 1.12 | 1.22 | 1.15 |
| cell pole | 3 | 1.46 | 1.08 | 1.28 | 1.11 | 1.49 | 1.29 | 1.1 |
| cell projection | 159 | 1.04 | 1.05 | 1.18 | -1.0 | 1.11 | 1.26 | 1.13 |
| cell projection assembly | 64 | -1.14 | 1.06 | 1.16 | 1.07 | 1.16 | 1.01 | 1.05 |
| cell projection cytoplasm | 1 | 1.03 | 1.24 | 1.01 | 1.09 | 1.02 | -1.11 | 1.01 |
| cell projection membrane | 4 | -1.03 | 1.05 | 1.14 | 1.11 | 1.34 | 1.84 | 1.38 |
| cell projection morphogenesis | 358 | 1.11 | 1.08 | 1.23 | 1.04 | 1.24 | 1.23 | 1.23 |
| cell projection organization | 408 | 1.12 | 1.08 | 1.23 | 1.04 | 1.24 | 1.23 | 1.23 |
| cell projection part | 75 | 1.15 | 1.03 | 1.15 | -1.04 | 1.1 | 1.34 | 1.14 |
| cell proliferation | 156 | 1.11 | 1.12 | 1.26 | 1.11 | 1.32 | 1.15 | 1.12 |
| cell proliferation involved in compound eye morphogenesis | 1 | -1.2 | 1.15 | 1.53 | 1.19 | 1.27 | 1.15 | 1.24 |
| cell rearrangement involved in Malpighian tubule morphogenesis | 3 | 2.04 | 1.05 | 1.89 | -1.07 | 1.16 | 1.0 | 1.3 |
| cell recognition | 57 | 1.01 | -1.01 | 1.18 | 1.01 | 1.28 | 1.17 | 1.15 |
| cell redox homeostasis | 50 | 1.14 | 1.05 | 1.09 | 1.13 | 1.1 | 1.12 | -1.05 |
| cell surface | 19 | -1.26 | 1.06 | 1.15 | 1.03 | 1.17 | 1.1 | 1.16 |
| cell surface binding | 17 | 1.52 | -1.27 | -1.19 | -1.21 | -1.12 | 1.67 | 1.0 |
| cell surface receptor signaling pathway | 482 | 1.17 | -1.01 | 1.15 | -1.01 | 1.13 | 1.17 | 1.12 |
| cell surface receptor signaling pathway involved in heart development | 3 | 1.09 | 1.1 | 1.13 | 1.08 | 1.18 | 1.14 | 2.09 |
| cell tip | 1 | 3.87 | -1.1 | 1.38 | 1.1 | 2.2 | 1.95 | 1.38 |
| cell volume homeostasis | 2 | 1.92 | 1.08 | -1.06 | -1.08 | 2.11 | 2.25 | 1.09 |
| cell wall macromolecule catabolic process | 9 | -1.18 | -1.16 | -1.42 | -1.31 | -1.28 | -2.35 | -1.08 |
| cell wall macromolecule metabolic process | 9 | -1.18 | -1.16 | -1.42 | -1.31 | -1.28 | -2.35 | -1.08 |
| cell wall organization or biogenesis | 9 | -1.18 | -1.16 | -1.42 | -1.31 | -1.28 | -2.35 | -1.08 |
| cell-cell adherens junction | 13 | 1.51 | 1.27 | 1.67 | 1.06 | 1.61 | 1.75 | 1.74 |
| cell-cell adhesion | 54 | 1.19 | -1.01 | 1.06 | -1.05 | 1.29 | 1.29 | 1.35 |
| cell-cell adhesion involved in establishment of planar polarity | 1 | 1.3 | 1.94 | 1.14 | 1.03 | 1.07 | 1.88 | 1.31 |
| cell-cell junction | 66 | 1.52 | -1.07 | 1.19 | -1.11 | 1.18 | 1.85 | 1.41 |
| cell-cell junction assembly | 36 | 1.91 | -1.1 | 1.31 | -1.15 | 1.22 | 2.16 | 1.42 |
| cell-cell junction maintenance | 2 | -1.01 | 1.25 | 1.94 | 1.07 | 1.78 | 1.99 | 1.84 |
| cell-cell junction organization | 45 | 1.62 | -1.06 | 1.35 | -1.1 | 1.25 | 1.89 | 1.32 |
| cell-cell signaling | 419 | 1.13 | 1.06 | 1.16 | 1.07 | 1.2 | 1.18 | 1.08 |
| cell-cell signaling involved in cell fate commitment | 189 | 1.17 | 1.06 | 1.11 | 1.08 | 1.2 | 1.17 | 1.05 |
| cell-matrix adhesion | 16 | -1.41 | 1.01 | 1.24 | -1.06 | 1.3 | -1.06 | 1.21 |
| cell-substrate adherens junction | 21 | 1.3 | 1.08 | 1.33 | 1.01 | 1.35 | 1.25 | 1.25 |
| cell-substrate adhesion | 18 | -1.4 | 1.01 | 1.22 | -1.05 | 1.29 | -1.09 | 1.19 |
| cell-substrate junction | 22 | 1.32 | 1.08 | 1.37 | 1.01 | 1.39 | 1.3 | 1.26 |
| cell-substrate junction assembly | 1 | -1.1 | -1.15 | -1.07 | -1.18 | 1.52 | 1.28 | 1.24 |
| cell-type specific apoptotic process | 15 | 1.32 | 1.04 | 1.28 | -1.05 | 1.01 | 1.08 | 1.27 |
| cellular acyl-CoA homeostasis | 6 | -3.11 | -1.44 | -2.62 | 1.15 | 1.36 | -3.71 | -1.6 |
| cellular aldehyde metabolic process | 8 | 1.58 | -1.07 | -1.41 | -1.33 | -1.03 | 1.21 | 1.04 |
| cellular alkane metabolic process | 1 | 1.08 | 1.05 | 1.26 | 1.07 | 1.31 | 1.33 | 1.1 |
| cellular alkene metabolic process | 1 | -1.74 | 1.11 | -2.01 | 1.51 | 1.27 | -1.87 | -1.55 |
| cellular amide catabolic process | 1 | 2.85 | -1.01 | 1.16 | 1.03 | -1.08 | 1.74 | -1.1 |
| cellular amide metabolic process | 5 | -1.4 | -1.19 | -1.57 | -1.07 | -1.0 | -1.05 | -1.49 |
| cellular amine metabolic process | 179 | -1.01 | 1.03 | -1.09 | -1.01 | 1.01 | 1.13 | -1.01 |
| cellular amino acid biosynthetic process | 39 | 1.02 | 1.06 | -1.29 | -1.04 | -1.12 | 1.11 | 1.06 |
| cellular amino acid catabolic process | 26 | 1.02 | -1.11 | -1.05 | -1.1 | 1.01 | 1.7 | -1.18 |
| cellular amino acid metabolic process | 161 | -1.02 | 1.04 | -1.09 | -1.01 | 1.01 | 1.14 | -1.04 |
| cellular aromatic compound metabolic process | 72 | 1.45 | -1.01 | -1.02 | -1.0 | -1.03 | 1.22 | 1.11 |
| cellular biogenic amine biosynthetic process | 15 | 1.13 | -1.22 | -1.12 | -1.08 | -1.06 | 1.41 | 1.13 |
| cellular biogenic amine catabolic process | 5 | -1.3 | 1.11 | -1.68 | -1.14 | -1.45 | -2.28 | 1.45 |
| cellular biogenic amine metabolic process | 29 | 1.1 | -1.1 | -1.15 | -1.04 | -1.12 | 1.08 | 1.25 |
| cellular biosynthetic process | 948 | 1.19 | 1.05 | 1.09 | 1.06 | 1.14 | 1.19 | 1.03 |
| cellular calcium ion homeostasis | 10 | 1.86 | -1.02 | 1.36 | -1.1 | -1.04 | 1.64 | 1.18 |
| cellular carbohydrate biosynthetic process | 22 | 1.52 | -1.16 | -1.16 | -1.14 | 1.15 | 1.68 | 1.12 |
| cellular carbohydrate catabolic process | 39 | 1.53 | 1.02 | -1.21 | -1.06 | -1.05 | 1.4 | 1.2 |
| cellular carbohydrate metabolic process | 165 | -1.04 | -1.01 | -1.23 | 1.0 | 1.01 | -1.04 | -1.1 |
| cellular catabolic process | 329 | 1.02 | 1.05 | 1.09 | 1.07 | 1.15 | 1.03 | 1.01 |
| cellular cation homeostasis | 29 | 1.01 | 1.02 | 1.39 | -1.05 | -1.07 | 1.29 | 1.04 |
| cellular chemical homeostasis | 58 | -1.02 | -1.02 | 1.04 | -1.15 | -1.07 | 1.16 | 1.05 |
| cellular component assembly | 455 | 1.19 | 1.06 | 1.24 | 1.05 | 1.23 | 1.24 | 1.12 |
| cellular component assembly at cellular level | 446 | 1.19 | 1.06 | 1.24 | 1.05 | 1.23 | 1.23 | 1.12 |
| cellular component assembly involved in morphogenesis | 135 | 1.25 | 1.03 | 1.17 | 1.01 | 1.15 | 1.18 | 1.06 |
| cellular component biogenesis | 506 | 1.2 | 1.07 | 1.25 | 1.07 | 1.24 | 1.23 | 1.11 |
| cellular component biogenesis at cellular level | 87 | 1.26 | 1.15 | 1.28 | 1.23 | 1.29 | 1.18 | 1.07 |
| cellular component disassembly | 27 | -1.1 | 1.18 | 1.3 | 1.14 | 1.29 | 1.09 | 1.04 |
| cellular component disassembly at cellular level | 27 | -1.1 | 1.18 | 1.3 | 1.14 | 1.29 | 1.09 | 1.04 |
| cellular component disassembly involved in apoptotic process | 4 | -1.16 | 1.19 | 1.65 | 1.21 | 1.51 | -1.05 | -1.11 |
| cellular component maintenance | 23 | -1.02 | 1.04 | 1.3 | 1.14 | 1.3 | -1.03 | 1.0 |
